Part IV · Maintenance · Estimated reading time 130 minutes · Prerequisites: Chapters 3, 16, 19, 22
In This Chapter
- Learning Objectives
- 26.1 Seven Jobs, One Organ
- 26.2 The Nephron
- 26.3 Renal Blood Supply: Two Capillary Beds in Series
- 26.4 Glomerular Filtration
- 26.5 Tubular Reabsorption and Secretion, Segment by Segment
- 26.6 The Countercurrent Mechanism
- 26.7 Regulating Water and Sodium — Two Separate Problems
- 26.8 Renal Clearance and the Assessment of Function
- 26.9 Micturition
- 26.10 Advanced Topic · The Cardiorenal Syndrome, Kidney Injury, and Diuretics
- Chapter Summary
- Case File 26 · Resolution
- Systems Integration Case File · Entry 26
- Review
- Key Terms
26. The Urinary System
Kidney Structure, Nephron Function, and Fluid Balance
Case File 26 — "The Number That Barely Moved"
Six weeks after discharge, Amara Osei sits in a nephrology clinic. She feels, she says, "mostly fine — tired." Her ankles swell by evening. She is taking eight medications, and the two that brought her here are lisinopril, an ACE inhibitor, and furosemide, a loop diuretic.
The nephrologist does something almost nobody had done before: she reads Amara's creatinine backwards, pulling every value the health system has ever recorded.
| Measurement | Value | Reference range | Read |
|---|---|---|---|
| Serum creatinine — 3 years ago (routine physical) | 0.9 mg/dL | 0.5–1.1 (women) | Normal |
| Serum creatinine — 2 years ago | 1.0 mg/dL | 0.5–1.1 | Normal |
| Serum creatinine — admission, day 1 | 1.1 mg/dL | 0.5–1.1 | Upper normal |
| Serum creatinine — today, week 6 | 1.4 mg/dL | 0.5–1.1 | High |
| Estimated GFR (CKD-EPI) | 46 mL/min/1.73 m² | > 90 | Stage G3a |
| Urine albumin-to-creatinine ratio | 180 mg/g | < 30 | Moderately increased (A2) |
| Serum potassium | 4.9 mEq/L | 3.5–5.0 | Upper normal |
| Serum bicarbonate | 21 mEq/L | 22–28 | Low |
| Hemoglobin | 11.2 g/dL | 12.0–15.5 (women) | Low |
| Serum phosphate | 4.4 mg/dL | 2.5–4.5 | Upper normal |
| Intact PTH | 88 pg/mL | 15–65 | High |
| Blood pressure | 138/84 mm Hg | target < 130/80 | Above target |
The nephrologist's summary sentence is this: "Chronic kidney disease, stage 3a, albuminuric, almost certainly diabetic and hypertensive in origin, accelerated by six weeks of heart failure. Continue the ACE inhibitor. Continue the loop diuretic. Recheck in four weeks."
Amara, who is a charge nurse and reads her own chart, asks the three questions that this chapter exists to answer.
Three questions to hold on to.
- "You are telling me I have lost about half my kidney function. My creatinine went from 0.9 to 1.4. That is not half of anything. How can the main blood test for a kidney barely move while the kidney loses half its capacity?"
- "My heart is the sick organ. Why did my kidneys start holding on to salt and water — and why does everyone keep saying that the fluid I am holding is making the heart worse? Draw me that loop."
- "The lisinopril raised my creatinine. You just told me a high creatinine is bad. Why would you deliberately keep giving me a drug that makes my kidney number worse?"
Learning Objectives
By the end of this chapter you should be able to:
- List the seven functions of the kidney and name, for each, the specific renal structure or secreted product responsible.
- Describe the retroperitoneal position of the kidneys, their vertebral levels, the three coverings, and the internal arrangement of cortex, medulla, pyramids, columns, calyces, and pelvis.
- Trace a drop of urine from a renal papilla to the outside of the body, naming every structure, and explain why the male and female urethra differ and what that difference costs.
- Distinguish cortical from juxtamedullary nephrons and explain why only the second type can produce concentrated urine.
- Name the three layers of the filtration barrier and state what each excludes by size and by charge; explain albuminuria as a specific failure of that barrier.
- Identify the three cell populations of the juxtaglomerular complex and give each a job.
- Trace blood from the renal artery to the renal vein through two capillary beds in series, and predict the effect on renal blood flow and GFR of constricting or dilating the afferent versus the efferent arteriole.
- Calculate net filtration pressure from glomerular hydrostatic, capsular hydrostatic, and blood colloid osmotic pressures, and explain why NFP is small while GFR is enormous.
- Explain renal autoregulation by the myogenic mechanism and by tubuloglomerular feedback, and state the pressure range over which it operates.
- Build the renin–angiotensin–aldosterone system from its three renin stimuli through to its five effects, and use it to explain both why an ACE inhibitor raises creatinine and why it protects the glomerulus.
- Describe reabsorption and secretion segment by segment, naming the transporters, and justify the claim that the basolateral Na⁺/K⁺ ATPase powers essentially all of it.
- Define transport maximum and renal threshold, and calculate a filtered load to predict whether glucose appears in the urine.
- Explain the countercurrent multiplier, urea recycling, and the countercurrent exchanger, and account for the 300 → 1200 mOsm medullary gradient.
- Describe ADH's action on aquaporin-2 and contrast the production of maximally dilute with maximally concentrated urine.
- Separate water balance (osmolality, ADH) from sodium balance (volume, aldosterone and the natriuretic peptides) and explain why the distinction matters clinically.
- Define renal clearance, compare inulin, creatinine, and PAH, and explain the hyperbolic relationship between creatinine and GFR, renal reserve, and hyperfiltration.
- Interpret a urinalysis, including specific gravity, protein, glucose, blood, nitrite, leukocyte esterase, and the major urinary casts.
- Describe the micturition reflex, the two sphincters, and the mechanisms of incontinence and retention.
- Diagram the cardiorenal loop and identify every point at which a drug can interrupt it.
- Classify acute kidney injury as prerenal, intrinsic, or postrenal, stage chronic kidney disease, and explain its four characteristic metabolic consequences.
26.1 Seven Jobs, One Organ
Ask most people what the kidney does and they will say it makes urine. That is true in the way that "the heart makes noise" is true — it names the byproduct rather than the purpose. Urine is what is left over after the kidney has finished doing the seven things it actually does.
THE SEVEN FUNCTIONS OF THE KIDNEY — and the structure that performs each
1 FILTRATION AND EXCRETION OF WASTE
urea (protein N) · creatinine (muscle) · uric acid (nucleic acids) ·
drugs and their metabolites · excess of almost anything
─► glomerulus filters; tubule secretes what filtration missed
2 WATER AND ELECTROLYTE BALANCE
Na+ K+ Cl- Ca2+ Mg2+ PO4(3-) and total body water
─► the tubule: 180 L filtered per day, ~178.5 L reabsorbed, selectively
3 ACID-BASE BALANCE
reclaims filtered HCO3- ; generates NEW HCO3- ; excretes H+ as
titratable acid and as NH4+
─► proximal tubule + type A intercalated cells [Ch. 22, 31]
4 BLOOD PRESSURE REGULATION
short term: RENIN ─► angiotensin II ─► vasoconstriction
long term: control of Na+ and therefore of blood VOLUME
─► granular cells of the afferent arteriole [Ch. 16, 19]
5 ERYTHROPOIETIN SECRETION
O2 sensed in the cortical interstitium ─► EPO ─► red marrow
─► peritubular interstitial fibroblasts [Ch. 17]
6 CALCITRIOL ACTIVATION
25-OH vitamin D ── 1-alpha-hydroxylase ──► 1,25-(OH)2 vitamin D
the LAST and rate-limiting step; nowhere else does it
─► proximal tubule cells [Ch. 6, 16]
7 GLUCONEOGENESIS
during a long fast the renal cortex makes up to ~40% of new glucose
─► proximal tubule cells [Ch. 24]
══════════════════════════════════════════════════════════════════════
Note that only ONE of the seven is what the public calls "kidney
function." Lose the kidney and you lose all seven — which is why
chronic kidney disease produces ANEMIA (5), BONE DISEASE (6), and
ACIDOSIS (3) long before it produces anything that looks urinary.
Figure 26.1 — The kidney's seven functions, each mapped to the structure that performs it.
Described: A list of seven kidney functions, each paired with the renal structure responsible. One, filtration and excretion of wastes — urea from protein nitrogen, creatinine from muscle, uric acid from nucleic acids, and drugs — performed by the glomerulus, which filters, and the tubule, which secretes what filtration missed. Two, water and electrolyte balance for sodium, potassium, chloride, calcium, magnesium, phosphate, and total body water, performed by the tubule, which reabsorbs about 178.5 of the 180 litres filtered each day, selectively. Three, acid-base balance: reclaiming filtered bicarbonate, generating new bicarbonate, and excreting hydrogen ion as titratable acid and as ammonium, performed by the proximal tubule and the type A intercalated cells. Four, blood pressure regulation, both short term through renin and angiotensin II causing vasoconstriction and long term through control of sodium and therefore blood volume, performed by the granular cells of the afferent arteriole. Five, erythropoietin secretion in response to oxygen sensed in the cortical interstitium, performed by peritubular interstitial fibroblasts. Six, activation of calcitriol by 1-alpha-hydroxylase, the last and rate-limiting step of vitamin D activation, performed nowhere else in the body but the proximal tubule. Seven, gluconeogenesis, in which the renal cortex can supply up to forty percent of newly made glucose during a prolonged fast. The closing note observes that only one of the seven is what the public calls kidney function, which is why chronic kidney disease produces anemia, bone disease, and acidosis long before it produces any urinary symptom.
Hold that figure in mind for the whole chapter. Every one of Amara's abnormal numbers in the Case File maps onto one of those seven lines. Her hemoglobin of 11.2 g/dL is line 5. Her PTH of 88 pg/mL is line 6. Her bicarbonate of 21 mEq/L is line 3. Her blood pressure is line 4. She does not have "a kidney problem." She has seven of them, at different stages.
Position: behind everything, high up, and asymmetric
The kidneys are retroperitoneal — they lie behind the parietal peritoneum rather than within the peritoneal cavity (Chapter 1). This is not trivia. It means a surgeon can reach a kidney from the flank without opening the abdominal cavity; it means bleeding from a kidney is contained in a compartment rather than spilling free; and it means that kidney pain is felt in the back and flank, not in the front of the abdomen.
They sit between the levels of T12 and L3, which surprises most students — this is higher than people expect, with the superior poles tucked beneath the eleventh and twelfth ribs and therefore inside the thoracic cage. A stab wound below the ribs on the back can still hit a kidney. Cardiopulmonary structures and renal structures are neighbors.
The right kidney sits roughly 1.5–2 cm lower than the left, displaced downward by the mass of the liver above it. This asymmetry is worth remembering because it appears on every ultrasound report and every CT scan you will ever read.
Each kidney is about 11–14 cm long, 6 cm wide, 3 cm thick, and weighs roughly 130–150 g — a bit larger than a clenched fist. Together the two organs are about 0.4% of body mass and receive 20–25% of cardiac output, roughly 1.1 L of blood every minute. Nothing else in the body has a perfusion-to-mass ratio remotely like it, and the reason is the subject of §26.3: the kidney is not perfused to feed itself. It is perfused because blood is the raw material it processes.
Three coverings
From deep to superficial:
| Layer | Composition | Job |
|---|---|---|
| Fibrous (renal) capsule | Dense irregular connective tissue, adherent to the surface | Keeps the kidney's shape; a barrier to spreading infection; the structure that stretches painfully when a kidney swells acutely |
| Perirenal fat capsule | Adipose tissue | Mechanical cushion against the shocks of running, jumping, and being struck |
| Renal fascia | Dense fibrous outer envelope, continuous with the fascia over the diaphragm and the great vessels | Anchors the kidney and the adrenal gland to the posterior body wall |
The fat matters more than it sounds. In rapid, severe weight loss the perirenal fat is consumed, and the kidney can descend — nephroptosis — far enough that the ureter kinks and urine backs up. And the fibrous capsule's inelasticity explains a clinical rule of thumb: anything that swells a kidney quickly (acute pyelonephritis, acute obstruction) hurts severely, while anything that swells it slowly (polycystic kidney disease over decades) may not hurt at all — the same rate-versus-volume logic as cardiac tamponade in Chapter 1.
Internal anatomy
THE KIDNEY IN CORONAL SECTION (right kidney, anterior view)
╭───────────────────────────────────────────────────────────╮
│ RENAL CORTEX (outer ~1 cm; all glomeruli live here) │
│ ╭──────────────────────────────────────────────────────╮ │
│ │ ▲ cortical radiate (interlobular) vessels │ │
│ │ ┌───┴──── RENAL COLUMN ────┐ │ │
│ │ │ (cortical tissue dipping │ │ │
│ │ │ BETWEEN pyramids) │ │ │
│ │ ╰──┬────────────────────────╯ │ │
│ ╰─────┼───────────────────────────────────────────────╯ │
│ │ │
│ ╱───┴───╲ ╱───────╲ ╱───────╲ ◄─ RENAL MEDULLA │
│ ╱ RENAL ╲ ╱ PYRAMID ╲ ╱ PYRAMID ╲ (8–18 pyramids) │
│ │ PYRAMID │ striped │ striped │ │
│ │ striped │ = parallel│ = parallel│ stripes are loops │
│ │ │ tubules │ tubules │ of Henle + vasa │
│ ╲ ╱ ╲ ╱ ╲ ╱ recta + collecting │
│ ╲__▼__ ╱ ╲__▼__ ╱ ╲__▼__ ╱ ducts, all running │
│ PAPILLA PAPILLA PAPILLA the same direction │
│ ○ ○ ○ │
│ │ │ │ ◄ urine drips out │
│ ╭──┴──╮ ╭──┴──╮ ╭──┴──╮ of ~20 openings │
│ │MINOR│ │MINOR│ │MINOR│ per papilla │
│ │CALYX│ │CALYX│ │CALYX│ │
│ ╰──┬──╯ ╰──┬──╯ ╰──┬──╯ │
│ ╰─────┬──────╯───────────╯ │
│ ╭────┴─────╮ MAJOR CALYX (2–3 per kidney) │
│ ╰────┬─────╯ │
│ ╭─────┴──────╮ │
│ │RENAL PELVIS │ ◄── funnel; SMOOTH MUSCLE in wall │
│ ╰─────┬───────╯ (peristalsis starts here) │
╰──────────────┼────────────────────────────────────────────╯
RENAL HILUM: │ ── renal ARTERY (in, posterior to vein)
medial │ ── renal VEIN (out, most anterior)
concavity ▼ ── URETER (out, most posterior)
URETER mnemonic, front to back: V-A-U
═════════════════════════════════════════════════════════════════
THE ONE-SENTENCE RULE: FILTRATION happens only in the CORTEX.
CONCENTRATION happens only in the MEDULLA. Every structural fact
above is a consequence of keeping those two jobs in separate places.
Figure 26.2 — Coronal section of the kidney, from cortex to ureter.
Described: A coronal section through the right kidney seen from the front. The outermost zone is the renal cortex, roughly one centimetre thick, which contains every glomerulus in the kidney; cortical radiate, also called interlobular, vessels run through it radially. Cortical tissue also dips inward between the pyramids as the renal columns. Deep to the cortex lies the renal medulla, made of eight to eighteen cone-shaped renal pyramids whose striped appearance comes from loops of Henle, vasa recta, and collecting ducts all running in parallel in the same direction. Each pyramid narrows to a renal papilla at its tip, where urine drips from about twenty openings into a cup-shaped minor calyx. Minor calyces converge into two or three major calyces, which converge into the renal pelvis, a funnel whose wall contains smooth muscle where peristalsis begins. The pelvis narrows into the ureter. All vessels and the ureter enter and leave at the renal hilum, the medial concavity; from anterior to posterior the order is vein, artery, ureter. The governing rule stated at the bottom is that filtration happens only in the cortex and concentration happens only in the medulla, and that every structural feature above follows from keeping those two jobs in separate places.
Two structural observations that pay off later. First, the medulla looks striped because it is striped: every tubule and vessel in a pyramid runs parallel to every other, straight from the corticomedullary junction toward the papilla. That parallel geometry is the physical precondition for the countercurrent mechanism of §26.6, which requires fluid to flow in opposite directions in adjacent tubes. Second, all glomeruli are in the cortex. A kidney whose cortex has thinned has lost filtering units, and that is exactly what an ultrasound measures when it reports cortical thickness.
Ureters, bladder, and urethra
The ureters are 25–30 cm muscular tubes running retroperitoneally from renal pelvis to bladder. They do not merely drain — they pump, with peristaltic waves at one to five per minute generated by pacemaker cells in the renal pelvis. Urine reaches the bladder against gravity even if you are standing on your head.
Three points of natural narrowing determine where a kidney stone lodges:
- The ureteropelvic junction, where the funnel becomes the tube.
- The pelvic brim, where the ureter crosses the common iliac vessels.
- The ureterovesical junction, where the ureter enters the bladder wall — the narrowest point of all, and the commonest site of impaction.
The ureter enters the bladder obliquely, tunnelling through the detrusor muscle for 1–2 cm before opening. There is no anatomical valve; the tunnel is the valve. When bladder pressure rises, it compresses the intramural segment shut. This is a superb piece of engineering, and its failure — a short or straight tunnel, congenital or acquired — produces vesicoureteral reflux, in which infected bladder urine is driven up to the kidney with every void.
The urinary bladder is a collapsible muscular sac in the pelvis, posterior to the pubic symphysis. Its wall has three interwoven layers of smooth muscle collectively called the detrusor, lined by transitional epithelium (urothelium) whose surface "umbrella" cells flatten as the organ fills — the epithelium introduced in Chapter 1 as the anatomy of an organ that must change volume tenfold. Interior folds called rugae disappear as it distends.
One region of the bladder floor never has rugae and never changes shape: the trigone, a smooth triangle defined by the two ureteric orifices posterolaterally and the internal urethral orifice anteriorly. It is developmentally distinct (it derives from the mesonephric ducts, not the bladder proper), it is the most sensitive region of the bladder, and it is where infections and tumors preferentially settle. Moderate capacity is 400–600 mL; the first conscious urge arrives at about 150–300 mL.
The urethra carries urine out. Here the sexes differ sharply, and the difference has consequences.
| Female urethra | Male urethra | |
|---|---|---|
| Length | 3–4 cm | 18–20 cm |
| Regions | One | Prostatic, intermediate (membranous), spongy (penile) |
| Function | Urinary only | Urinary and reproductive — shared final common pathway |
| External opening | Anterior to the vaginal orifice, posterior to the clitoris | Tip of the glans penis |
| Consequence | Short path from a heavily colonized perineum to a sterile bladder — urinary tract infection is many times more common | Long path with a prostatic segment that enlarges with age — obstruction is far more common |
Both sexes have two sphincters: the internal urethral sphincter, smooth muscle at the bladder neck, involuntary, sympathetically maintained; and the external urethral sphincter, skeletal muscle in the urogenital diaphragm, voluntary, innervated by the pudendal nerve from S2–S4. Two sphincters, two nervous systems, one tube — the anatomy of §26.9.
Development · Why the Kidney Climbs, and What Happens When It Cannot
The human embryo makes three kidneys in succession. The pronephros appears in week 4 and regresses within days. The mesonephros functions briefly and then largely disappears — but its duct, the mesonephric (Wolffian) duct, survives to become the male genital duct system (Chapter 27). The metanephros, appearing in week 5, becomes the definitive kidney.
It forms by a reciprocal conversation between two tissues. A ureteric bud sprouts from the mesonephric duct and invades a mass of metanephric blastema. The blastema tells the bud to branch; each branch tells the surrounding blastema to condense into nephrons. The bud's branching produces the ureter, pelvis, calyces, and collecting ducts; the blastema produces everything from the renal corpuscle to the distal convoluted tubule. The nephron and its collecting duct have separate embryonic origins and meet in the middle — which is precisely why the connecting tubule is a transitional segment with a mixed cell population.
The metanephros forms in the pelvis, at about the S1–S2 level, with its hilum facing anteriorly. Between weeks 6 and 9 the trunk elongates faster than the kidney is tethered, and the kidney appears to ascend to T12–L3 while rotating 90 degrees medially, bringing the hilum to face medially. As it climbs it takes arterial supply from successively higher levels of the aorta, discarding the lower vessels. Sometimes it does not discard them: accessory renal arteries are present in 25–30% of people and are a routine finding at surgery.
Three classic anomalies fall straight out of this account:
- Horseshoe kidney (about 1 in 500). The lower poles fuse across the midline. The fused mass then ascends until it catches on the inferior mesenteric artery and stops. A single arterial branch determines the final position of an entire organ. Horseshoe kidneys are associated with obstruction, stones, and infection, and are common in Turner syndrome.
- Pelvic kidney. Ascent fails altogether; the kidney remains where it formed. It usually works, but it is easy to mistake for a pelvic mass and easy to injure in pelvic surgery.
- Duplicated ureter (about 1 in 125). Either the ureteric bud splits early or two buds form. By the Weigert–Meyer rule, the ureter draining the upper pole inserts inferomedially and often ectopically — prone to obstruction — while the lower pole ureter inserts superolaterally with a short intramural tunnel, and is therefore prone to reflux. Two predictable, opposite complications from a single developmental event.
Check Your Understanding 26.1
- A patient has flank pain and a fever. Why does the location of the pain place the problem in the retroperitoneum rather than in the peritoneal cavity?
- The kidneys are 0.4% of body mass and receive 20–25% of cardiac output. Explain why this ratio does not mean that kidney tissue has an extraordinary metabolic rate.
- Predict two distinct clinical consequences of the fact that the male urethra is five times longer than the female urethra.
Show answers
- The kidneys lie posterior to the parietal peritoneum, against the posterior body wall and the psoas muscle. Their pain is therefore transmitted by somatic and visceral afferents entering the cord at roughly T10–L1 and is referred to the flank and the costovertebral angle, not to the anterior abdominal wall. Anterior abdominal pain with peritoneal signs points instead to an intraperitoneal organ. The compartment also contains the problem: a ruptured renal artery aneurysm bleeds into a confined retroperitoneal space rather than freely into the abdomen, which changes both the physical findings and the rate of collapse.
- Because most of that blood flow is not being consumed — it is being processed. For the heart, brain, or exercising muscle, high flow exists to deliver oxygen. For the kidney, blood is the substrate: it must be presented to the glomeruli in enormous volume so that 180 L of plasma can be filtered each day. The proof is in the numbers: renal venous blood is still about 85–90% saturated with oxygen, far higher than coronary sinus blood at roughly 30%. The kidney extracts very little of the oxygen it is offered. (It is nevertheless a high-ATP organ in absolute terms, because of the sodium pumping in §26.5 — but its oxygen supply is so lavish that extraction stays low. The one exception, the outer medulla, is discussed in §26.5 and is why that region dies first in shock.)
- Any two of: urinary tract infection is far more common in women, because bacteria from the perineum have only 3–4 cm to travel to reach the bladder; urethral catheterization is technically easier and less traumatic in women; obstruction to urine flow is far more common in men, because the prostatic urethra passes through a gland that enlarges in most men after 50 (Chapter 27); and urethral injury in pelvic trauma is much more common in men, because the membranous urethra is fixed where it passes through the urogenital diaphragm and shears when the pelvis fractures.
26.2 The Nephron
A kidney is not really an organ in the way a heart is an organ. It is roughly one million identical microscopic machines wired in parallel, each one a complete filtering-and-recovery device, all draining into a common plumbing system. The machine is the nephron, and everything else — pyramids, calyces, pelvis — is scaffolding and drainage.
The number matters more than textbooks usually admit. Adult humans have between about 200,000 and 2.5 million nephrons per kidney, with a mean near one million. That tenfold range is set before birth — nephrogenesis stops at around 36 weeks of gestation and never restarts. You cannot make a new nephron. Every one you lose across your life is permanent, and someone born at the low end of that range (low birth weight, prematurity, maternal malnutrition) starts adult life with far less to lose. This single fact underlies much of the epidemiology of chronic kidney disease.
Each nephron has two parts: a renal corpuscle, which filters, and a renal tubule, which recovers. They perform opposite operations, and the ratio between them is the whole story of renal physiology: 180 litres in the front door, 1.5 litres out the back.
Two populations of nephron
THE NEPHRON, POSITIONED CORRECTLY — with its blood supply
(left: a CORTICAL nephron, ~85%. right: a JUXTAMEDULLARY nephron, ~15%)
afferent efferent
══ CORTEX ═════════ arteriole ══════ arteriole ═══════════════════════
╭──────╮ ╭──────╮
cortical │ RENAL│ ┌──DCT──┐ │ RENAL│ ┌──DCT──┐
radiate ──►│CORPUS│──┤ (5–8% │ │CORPUS│───┤ │
artery │ -CLE │ │ Na+) │ │ -CLE │ │ │
╰───┬──╯ └───┬───┘ ╰───┬──╯ └───┬───┘
│ PCT │ │ PCT │
┌───┴────┐ │ ┌───┴────┐ │
│ 65% of│ │ ╔═══════════╗ │ 65% │ │ ╔══════╗
│ EVERY-│ └─►║ COLLECTING║ │ │ └─►║COLLE-║
│ THING │ ║ DUCT ║ │ │ ║CTING ║
└───┬────┘ ║ ║ └───┬────┘ ║ DUCT ║
│ PERITUB- ║ ║ │ VASA ║ ║
─ ─ ─ ─ ─ ─ ─ ─│─ ULAR ─ ─ ─║─ ─ ─ ─ ─ ─║─ ─ ─ ─│─ RECTA ─ ─ ║─ ─ ─ ─
══ OUTER ╲ │ CAPIL- ║ ║ ╲ │ ║ ║ ║ ║
MEDULLA ╲ │ LARIES ║ ║ ╲ │ ║ ║ ║ ║
╲ │ ║ ║ ╲ │ ║ ║ ║ ║
short ╲│ ║ ║ ╲│ ║ ║ ║ ║
LOOP OF ╱ thick ║ ║ ╱ ║ ║ ║ ║
HENLE ╱ ascending ║ ║ ╱ ║ ║ ║ ║
═══════════════════════════ ║ ══════════║ ════╱═════║═║═══════║══════
══ INNER ║ ║ ╱ ║ ║ ║ ║
MEDULLA ║ ║ │ thin ║ ║ ║ ║
300 ──► 1200 ║ ║ │ desc ║ ║ ║ ║
mOsm/kg ║ ║ │ ╱ ║ ║ ║ ║
gradient ║ ║ ╲__╱ ║ ║ ║ ║
║ ║ LONG LOOP║ ║ ║ ║
╚═══▼═══════╝ OF HENLE ╚═╝ ╚══▼═══╝
══ PAPILLA ══════════════ to MINOR CALYX ═══════════════════════════
▼ URINE
SEGMENT ORDER (both types): renal corpuscle ─► PCT ─► descending thin
limb ─► ascending thin limb ─► thick ascending limb (with MACULA DENSA
at its end) ─► DCT ─► connecting tubule ─► COLLECTING DUCT ─► papilla
WHY THE LONG LOOPS MATTER: only juxtamedullary nephrons dip deep into
the medulla, and only they are wrapped by VASA RECTA. They BUILD the
medullary gradient. The other 85% merely USE it.
Figure 26.3 — Cortical and juxtamedullary nephrons, drawn in correct position relative to cortex and medulla, with their blood supply.
Described: Two nephrons drawn side by side against a background divided into cortex at the top, outer medulla in the middle, and inner medulla and papilla at the bottom. On the left is a cortical nephron, which makes up about eighty-five percent of the total: its renal corpuscle sits in the outer cortex, its proximal convoluted tubule reabsorbs about sixty-five percent of everything filtered, its loop of Henle is short and barely enters the outer medulla, and its distal convoluted tubule drains into a collecting duct. Its tubule is surrounded by peritubular capillaries arising from the efferent arteriole. On the right is a juxtamedullary nephron, about fifteen percent of the total: its corpuscle sits deep in the cortex at the corticomedullary junction, and its loop of Henle is long, descending as a thin descending limb far into the inner medulla, turning, and ascending as a thin then a thick ascending limb. Its efferent arteriole gives rise to long straight vessels called the vasa recta, which run alongside the long loop. Both nephrons follow the same segment order: renal corpuscle, proximal convoluted tubule, thin descending limb, thin ascending limb, thick ascending limb ending at the macula densa, distal convoluted tubule, connecting tubule, collecting duct, and papilla. The inner medulla is labeled with an osmotic gradient rising from 300 to 1200 milliosmoles per kilogram. The closing note states that only juxtamedullary nephrons, with their long loops and vasa recta, build that gradient, and that the other eighty-five percent of nephrons merely use it.
Cortical nephrons — about 85% — have their corpuscles in the outer cortex and short loops that barely cross into the medulla. Their tubules are embraced by a tangled net of peritubular capillaries. They do the bulk of the filtering.
Juxtamedullary nephrons — about 15% — have their corpuscles at the corticomedullary junction and loops that plunge deep toward the papilla. Their efferent arterioles give rise not to a capillary net but to vasa recta, long straight hairpin vessels that descend and ascend alongside the loops.
That 15% minority does something the majority cannot: it builds and maintains the medullary osmotic gradient, the 300-to-1200 mOsm/kg ramp that makes concentrated urine possible. Animals that must conserve water extremely have longer loops and a higher proportion of juxtamedullary nephrons; a desert kangaroo rat concentrates urine to about 6,000 mOsm/kg. Humans manage about 1,200–1,400. Loop length is destiny.
The renal corpuscle and the three filtration barriers
The renal corpuscle is a tuft of capillaries — the glomerulus — pushed into the blind, cup-shaped end of the tubule, the glomerular (Bowman's) capsule, exactly as a fist is pushed into a balloon (Chapter 1). The capsule's outer parietal layer is simple squamous epithelium and does nothing but contain. Its inner visceral layer is made of podocytes, and they do everything.
Filtrate crosses three layers in series. Each excludes something different, and each can fail independently.
THE FILTRATION MEMBRANE IN CROSS-SECTION (total thickness ~0.3 µm)
══ CAPILLARY LUMEN ═══════════════════════════════════════════════
● RBC (7 µm) ● platelet ● WBC ── all far too large
~ albumin (69 kDa, 3.6 nm, NET NEGATIVE at pH 7.4)
· glucose (180 Da) · urea · Na+ · creatinine · water
─────────────────────────────────────────────────────────────────
BARRIER 1 · FENESTRATED ENDOTHELIUM
┌────┐ ○ ○ ○ ┌────┐ ○ ○ ○ ┌────┐ fenestrae 70–100 nm
│cell│ (pores) │cell│ (pores) │cell│ NO diaphragms
└────┘ └────┘ └────┘ thick NEGATIVE glycocalyx
EXCLUDES: all formed elements — RBCs, WBCs, platelets
PASSES: plasma and everything dissolved in it
─────────────────────────────────────────────────────────────────
BARRIER 2 · GLOMERULAR BASEMENT MEMBRANE (~300 nm, three laminae)
░░░░░░░░░░░░░░░░ lamina rara interna ── heparan sulfate (−)
████████████████ lamina densa ── type IV collagen mesh
░░░░░░░░░░░░░░░░ lamina rara externa ── heparan sulfate (−)
EXCLUDES: most proteins > ~4 nm / > ~40–70 kDa, AND — crucially —
ANIONIC proteins of ANY size, by electrostatic repulsion
PASSES: water, ions, glucose, amino acids, urea, small peptides
─────────────────────────────────────────────────────────────────
BARRIER 3 · PODOCYTE FILTRATION SLITS
╲__pedicel__╱ ╲__pedicel__╱ ╲__pedicel__╱ interdigitating
▓▓▓▓▓▓▓▓▓▓▓ ═ ▓▓▓▓▓▓▓▓▓▓▓ ═ ▓▓▓▓▓▓▓▓▓▓▓ foot processes
▲ ▲
SLIT DIAPHRAGM (25–40 nm) — a zipper of NEPHRIN and
PODOCIN proteins. The FINAL size filter.
EXCLUDES: anything that squeezed past barriers 1 and 2
PASSES: the finished filtrate
─────────────────────────────────────────────────────────────────
══ CAPSULAR (BOWMAN'S) SPACE ═════════════════════════════════════
FILTRATE = plasma minus cells minus essentially all protein
~180 L/day. Normal albumin escape: < 30 mg per day.
┌───────────────────────────────────────────────────────────────┐
│ AMARA: urine albumin-to-creatinine ratio 180 mg/g │
│ = roughly 180 mg of albumin per day = SIX TIMES normal. │
│ Not enough to see on a dipstick. Enough to prove that │
│ barrier 2's charge and barrier 3's slits are failing. │
└───────────────────────────────────────────────────────────────┘
Figure 26.4 — The three layers of the filtration membrane and what each excludes.
Described: A cross-section through the glomerular filtration membrane, total thickness about 0.3 micrometres, drawn as three stacked barriers between the capillary lumen at the top and the capsular space at the bottom. In the lumen sit red blood cells seven micrometres across, platelets and white cells, albumin molecules of 69 kilodaltons and 3.6 nanometres carrying a net negative charge at physiological pH, and small solutes such as glucose, urea, sodium, and creatinine. Barrier one is the fenestrated endothelium, whose pores are 70 to 100 nanometres across and lack diaphragms and whose surface carries a thick negatively charged glycocalyx; it excludes all formed elements and passes plasma with everything dissolved in it. Barrier two is the glomerular basement membrane, about 300 nanometres thick and composed of three laminae: an inner lamina rara rich in negatively charged heparan sulfate, a central lamina densa of type four collagen mesh, and an outer lamina rara also rich in heparan sulfate. It excludes most proteins larger than about four nanometres or forty to seventy kilodaltons, and critically it excludes anionic proteins of any size by electrostatic repulsion, while passing water, ions, glucose, amino acids, urea, and small peptides. Barrier three is formed by interdigitating podocyte foot processes, or pedicels, separated by filtration slits of 25 to 40 nanometres that are bridged by a slit diaphragm built from the proteins nephrin and podocin; this is the final size filter. Below the three barriers lies the capsular space containing the filtrate — plasma minus cells and minus essentially all protein — at about 180 litres per day, with normal albumin escape under 30 milligrams per day. A boxed note records that Amara's urine albumin-to-creatinine ratio of 180 milligrams per gram corresponds to roughly 180 milligrams of albumin per day, about six times normal — too little to register on a standard dipstick, but enough to prove that the charge barrier of the basement membrane and the slit barrier of the podocytes are both failing.
Notice the logic of the stack. Barrier 1 is a coarse sieve that stops cells. Barrier 2 is a fine mesh that stops most proteins and a charged surface that stops negatively charged proteins even when they would otherwise fit. Barrier 3 is the final gate. Redundancy again: three sequential filters, so that a partial failure of one does not open the floodgates.
Albuminuria is what a failing barrier looks like. Albumin is right at the edge: 3.6 nm across a barrier that passes molecules up to about 4 nm. It stays in the blood almost entirely because it is negatively charged and the glycocalyx and basement membrane are negatively charged. Take away the charge — as sustained hyperglycemia does by degrading heparan sulfate — and albumin begins to slip through even though nothing has physically torn.
The kidney has one further line of defence: the proximal tubule retrieves nearly all of the small amount of albumin that does escape, using megalin and cubilin receptors to endocytose it. So a rising urine albumin means either that more is getting through the barrier or that the proximal tubule is overwhelmed, and usually both.
Amara's ACR of 180 mg/g is not a plumbing leak. It is a biopsy result you can obtain from a urine cup — direct evidence that her podocytes are stressed, that her basement membrane has lost charge selectivity, and, because albuminuria predicts progression better than creatinine does, evidence about her future rather than her past.
Histology · The Glomerulus, and Why Minimal Change Disease Is Called That
On a routine H&E section of renal cortex, a renal corpuscle is unmistakable: a dense ball of capillary loops sitting inside a clear ring — the capsular space — surrounded by a single thin layer of squamous parietal cells. At one pole the arterioles enter and leave (the vascular pole); at the opposite pole the proximal tubule begins (the urinary pole).
What you cannot do on H&E is tell the three cell types apart. Endothelial cells, mesangial cells, and podocytes all present as small dark nuclei in the tuft. Roughly, podocyte nuclei sit at the outer margin and are slightly larger and paler; mesangial nuclei sit centrally, in the axial regions between capillary loops; endothelial nuclei bulge into lumens. Pathologists count them, but honest ones admit the assignment is probabilistic.
Everything that matters about the filtration barrier is below the resolution of light microscopy, which is why renal biopsies are read three ways: light microscopy for architecture, immunofluorescence for what is deposited, and electron microscopy for the barrier itself. On EM you see the fenestrated endothelium, the trilaminar basement membrane, and the podocyte foot processes standing on it like a row of fingers.
Minimal change disease is named for what light microscopy shows: nothing. Glomeruli look normal, immunofluorescence is negative — and yet the patient is losing 10 g of protein a day and is grossly edematous. On EM the answer is immediate and total: every podocyte foot process has retracted and fused into a continuous sheet, obliterating the filtration slits. This is foot-process effacement, and it is the single most instructive image in renal pathology, because it proves that the barrier is a cellular structure maintained by a living cell, not a passive filter.
The mesangial cells deserve a sentence of their own. They are contractile pericyte-like cells in the axial space between capillary loops. They provide structural support, phagocytose trapped debris from the basement membrane, and contract in response to angiotensin II — reducing the surface area available for filtration. When they proliferate and lay down matrix, as they do in diabetes, the tuft becomes progressively occupied by scar. The nodular masses this produces are Kimmelstiel–Wilson lesions, and they are the histological signature of diabetic nephropathy.
The tubule, segment by segment
| Segment | Epithelium | Distinguishing feature | Principal job |
|---|---|---|---|
| Proximal convoluted tubule (PCT) | Simple cuboidal | Dense brush border; packed with mitochondria | Bulk reabsorption — 65% of Na⁺ and water, 100% of glucose and amino acids |
| Descending thin limb | Simple squamous | Aquaporin-1; almost no transporters | Water leaves passively; solute stays |
| Ascending thin limb | Simple squamous | Permeable to NaCl, not to water | Passive NaCl exit |
| Thick ascending limb (TAL) | Simple cuboidal | NKCC2 cotransporter; water-impermeable | Active NaCl reabsorption; the diluting segment |
| Macula densa | Tall, crowded cuboidal | Sits where the TAL touches its own corpuscle | Chemoreceptor for luminal NaCl |
| Distal convoluted tubule (DCT) | Simple cuboidal | No brush border; NCC cotransporter | Fine-tuned Na⁺ and Ca²⁺ reabsorption |
| Connecting tubule / collecting duct | Simple cuboidal → columnar | Principal cells and intercalated cells | The regulated segment: Na⁺, K⁺, H⁺, water, urea |
The collecting duct is worth pausing on because it is where hormones actually change outcomes. Its principal cells carry ENaC sodium channels, ROMK potassium channels, and aquaporin-2 — which is to say they are the target of aldosterone and of ADH. Its intercalated cells come in two flavours: type A secretes H⁺ and reclaims bicarbonate (the acidosis worker), type B does the reverse. The final composition of urine is decided here, in the last 5% of the tubule, by hormones responding to whole-body conditions.
Histology · Telling PCT from DCT on a Slide in Three Seconds
A section of renal cortex is a field of round tubule profiles cut at every angle, and the practical exam question is always the same: which are proximal and which are distal? Both are simple cuboidal epithelium. Four features separate them, and you should learn them as a set.
| Feature | PCT | DCT |
|---|---|---|
| Brush border | Present — a fuzzy pink fringe that fills and obscures the lumen | Absent — the lumen is wide, round, and clean |
| Cytoplasm | Intensely eosinophilic (deep pink) from densely packed mitochondria | Paler, less pink |
| Nuclei per profile | Few — typically 3–5, because cells are large | More — typically 5–8, because cells are smaller |
| Cell borders | Indistinct (extensive basolateral interdigitation) | More distinct |
There is also a counting clue that never fails: in any field of cortex, PCT profiles outnumber DCT profiles by roughly three or four to one, because the proximal tubule is far longer and more tortuous than the distal. If most of the tubules look one way, that way is proximal.
Now read the histology as physiology. The brush border multiplies apical surface area about twentyfold, because the PCT must reabsorb two-thirds of 180 litres a day. The mitochondrial density that makes the cytoplasm pink is fuel for the basolateral Na⁺/K⁺ ATPase that drives all of it. The DCT has neither because it handles a small, regulated trickle rather than a torrent. Structure is a statement of workload.
One more landmark to find: where a distal tubule brushes past its own renal corpuscle, look for a plaque of crowded, tall, dark nuclei on the tubule wall facing the vascular pole. That is the macula densa, and immediately across from it, in the wall of the afferent arteriole, are the pale granular cells that make renin.
The juxtaglomerular complex
At the vascular pole, where the tubule loops back to touch its own corpuscle, three cell populations form a control unit — the juxtaglomerular complex. It is the most consequential few hundred cells in the body's blood-pressure system.
- Macula densa cells — modified TAL cells, tall and tightly packed, facing the arterioles. They sense luminal NaCl concentration, which is a proxy for the flow rate through their own nephron, which is a proxy for that nephron's GFR.
- Granular (juxtaglomerular) cells — modified smooth muscle in the wall of the afferent arteriole, stuffed with secretory granules of renin. They are simultaneously mechanoreceptors that sense arteriolar stretch and the effector that releases renin.
- Extraglomerular mesangial cells — sit in the triangle between the two arterioles and the macula densa, connected to everything by gap junctions. They relay the signal.
Read the architecture as an argument. A structure that senses tubular fluid composition, senses arteriolar pressure, and secretes a blood-pressure hormone, all within a space smaller than a grain of salt, is a structure built to make one nephron's filtration rate answerable both to that nephron's own workload and to the pressure in the body as a whole. That is tubuloglomerular feedback (§26.4) and the renin system (§26.4, §26.7) sharing a single anatomical address.
Thread 1 · Structure Determines Function
Four claims in this section were made from anatomy alone, before any physiology:
- The medulla is striped because tubules and vessels run in parallel there — and parallel counterflow is the physical requirement for a countercurrent multiplier (§26.6).
- The PCT has a brush border and the DCT does not — so the PCT is the bulk absorber and the DCT is the regulator.
- The glomerulus is a capillary bed with an arteriole at both ends — so its pressure can be set independently of the rest of the circulation (§26.3).
- The juxtaglomerular complex places a chemoreceptor, a mechanoreceptor, and an endocrine cell in mutual contact — so a single nephron can regulate itself and the whole body's pressure with the same apparatus.
You could have predicted all four from the pictures. That is what it means to say anatomy is predictive.
Check Your Understanding 26.2
- A child is born at 28 weeks. Why does this raise their lifetime risk of chronic kidney disease, even if their kidneys work perfectly in childhood?
- A patient's urine contains albumin but no red or white blood cells. Which barrier or barriers must have failed, and which cannot have?
- Why would selective destruction of juxtamedullary nephrons impair urine concentration far more than destroying the same number of cortical nephrons?
Show answers
- Nephrogenesis ceases at about 36 weeks of gestation and never resumes. A baby born at 28 weeks completes far less of it and enters life at the low end of the nephron-number distribution — perhaps 300,000–500,000 per kidney rather than a million. Childhood function is normal because the nephrons present hypertrophy and hyperfilter to compensate. But that compensation is itself injurious over decades (§26.8), and there is less reserve to absorb the ordinary losses of adult life from hypertension, diabetes, and aging. Fewer nephrons, each working harder, for longer.
- The failure is in barrier 2 (the basement membrane's charge and size selectivity) and/or barrier 3 (the podocyte slit diaphragms). Barrier 1, the fenestrated endothelium, cannot have failed grossly — its job is to exclude cells, and no cells are appearing. This is exactly the pattern of early diabetic nephropathy and of the nephrotic diseases: a protein leak without a cell leak. The opposite pattern — red cells and red cell casts in the urine — implies frank disruption of the whole capillary wall, as in glomerulonephritis.
- Because only juxtamedullary nephrons have long loops of Henle reaching deep into the medulla, and only they are accompanied by vasa recta. They are the machinery that creates the 300-to-1200 mOsm medullary gradient. Cortical nephrons deliver fluid into collecting ducts that pass through that gradient and exploit it, but they do not generate it. Destroy the generators and every nephron loses the ability to concentrate, no matter how many filtering units remain. This is one reason that medullary diseases — and simple aging (see the Aging sidebar) — produce a striking loss of concentrating ability with relatively preserved GFR.
26.3 Renal Blood Supply: Two Capillary Beds in Series
Everywhere else in the body, blood passes through one capillary bed between an artery and a vein. In the kidney it passes through two, in series, separated by an arteriole. This is the single most important vascular fact in the chapter, and almost everything in §26.4 follows from it.
The path, in order:
renal artery → segmental → interlobar (in the renal columns, between pyramids)
→ arcuate (arching over the base of each pyramid) → cortical radiate
(interlobular, running out into the cortex) → AFFERENT ARTERIOLE
→ ★ GLOMERULUS (capillary bed 1) → EFFERENT ARTERIOLE
→ ★ PERITUBULAR CAPILLARIES / VASA RECTA (capillary bed 2)
→ cortical radiate vein → arcuate vein → interlobar vein → renal vein
The two beds are built for opposite jobs, and their pressures say so:
| Glomerular capillaries | Peritubular capillaries | |
|---|---|---|
| Fed by | Afferent arteriole | Efferent arteriole |
| Hydrostatic pressure | ~55 mm Hg — very high for a capillary | ~13–15 mm Hg — low |
| Colloid osmotic pressure of the blood in it | ~28–30 mm Hg at the start | ~30–35 mm Hg — high, because filtration just concentrated the plasma proteins |
| Net effect | Filtration along the whole length | Reabsorption along the whole length |
| Analogy | The pressure side of a pump | The suction side |
Look at what the arrangement achieves. The glomerulus is held at 55 mm Hg — roughly five times the pressure of an ordinary capillary — which is why it filters at an extraordinary rate. Then the efferent arteriole drops the pressure by 40 mm Hg before the blood reaches the tubule, so that the peritubular capillaries sit at low pressure. Meanwhile, removing a fifth of the plasma water at the glomerulus has concentrated the plasma proteins left behind, raising the blood's colloid osmotic pressure from ~28 to ~35 mm Hg. Low hydrostatic pressure plus high oncotic pressure is the exact recipe for pulling fluid in.
The kidney filters and reabsorbs with the same blood, in that order, using pressures it manufactures itself. No other organ does this.
Predict This
You can constrict either arteriole. Before reading on, work out all four cases and commit to answers:
- Constrict the afferent arteriole. What happens to renal blood flow? To the pressure inside the glomerulus? To GFR?
- Constrict the efferent arteriole. Same three questions.
(Answer: constricting the afferent arteriole is like pinching the hose upstream of a sprinkler — flow falls and pressure inside the sprinkler falls, so renal blood flow and GFR both go down. Constricting the efferent arteriole is like pinching the hose downstream — flow still falls, but pressure inside the sprinkler goes up, so renal blood flow falls while GFR rises. That dissociation is the whole trick, and it is what angiotensin II exploits.)
Why a resistance vessel on both sides is the key to everything
Because the glomerulus is bracketed by two adjustable resistances, the kidney can control glomerular pressure and renal blood flow as two semi-independent variables. Work through the table until it is automatic:
| Manoeuvre | Renal blood flow | Glomerular hydrostatic pressure | GFR | Filtration fraction | Physiological example |
|---|---|---|---|---|---|
| Afferent constriction | ↓↓ | ↓ | ↓ | ~unchanged or ↓ | High sympathetic tone; tubuloglomerular feedback; NSAIDs blocking prostaglandin-mediated dilation |
| Afferent dilation | ↑↑ | ↑ | ↑ | ~unchanged | Prostaglandins, nitric oxide, dopamine; the hyperfiltration of early diabetes |
| Efferent constriction | ↓ | ↑↑ | ↑ | ↑↑ | Angiotensin II — the rescue mechanism |
| Efferent dilation | ↑ | ↓↓ | ↓ | ↓↓ | ACE inhibitors and ARBs — the protective mechanism |
The bottom two rows are Case File question 3 in embryo, and we will finish the answer in §26.4. But state the paradox now, because it is the intellectual centre of the chapter:
Angiotensin II raises GFR by constricting the efferent arteriole. An ACE inhibitor therefore lowers GFR, and creatinine goes up. And that fall in GFR is exactly why the drug protects the kidney.
The efferent arteriole is more sensitive to angiotensin II than the afferent arteriole is, for receptor-density reasons, so at physiological concentrations angiotensin II acts on the efferent side selectively. At very high concentrations both constrict and GFR falls — which is why extreme RAAS activation in shock eventually shuts the kidney down.
Thread 3 · The Body Is Integrated
Filtration fraction — the proportion of the plasma arriving that is filtered — is normally about 20% (GFR 125 mL/min divided by renal plasma flow 625 mL/min). It is a small number with large consequences.
When the heart fails and renal perfusion drops, angiotensin II constricts efferent arterioles, and the filtration fraction rises — perhaps to 25–30%. GFR is defended. But now a larger fraction of the arriving plasma has been squeezed out at the glomerulus, so the blood entering the peritubular capillaries is more protein-concentrated than usual. Its colloid osmotic pressure is higher. That extra suction drives more proximal tubule reabsorption of sodium and water.
So the same hormonal act that protects filtration also causes salt retention, by pure physics, independent of aldosterone. A heart problem has become a fluid problem through a change in the oncotic pressure of blood leaving a capillary bed. Hold on to this: it is one of the four arms of the cardiorenal loop in §26.10.
26.4 Glomerular Filtration
Filtration at the glomerulus obeys the same Starling forces as any capillary (Chapter 19). Only the numbers are unusual.
NET FILTRATION PRESSURE — the arithmetic of 180 litres a day
══════════════ GLOMERULAR CAPILLARY ══════════════════════════════
HP(gc) GLOMERULAR HYDROSTATIC PRESSURE ~55 mm Hg
blood pressure inside the tuft │
═════════════════════════════════════════════════════▼═════
┌──────────────────────────────────────────────────────────┐
│ ▼ ▼ ▼ PUSHES FLUID OUT ▼ ▼ ▼ +55 │
└──────────────────────────────────────────────────────────┘
┌──────────────────────────────────────────────────────────┐
│ ▲ ▲ OP(gc) BLOOD COLLOID OSMOTIC −30 │
│ plasma proteins pull fluid BACK IN │
└──────────────────────────────────────────────────────────┘
┌──────────────────────────────────────────────────────────┐
│ ▲ ▲ HP(cs) CAPSULAR HYDROSTATIC −15 │
│ fluid already in Bowman's space pushes back │
└──────────────────────────────────────────────────────────┘
══════════════════════════════════════════════════════════
NET FILTRATION PRESSURE (NFP) = +10 mm Hg
───────────────────────────────────────────────
NFP = HP(gc) − [ HP(cs) + OP(gc) ]
= 55 − [ 15 + 30 ] = 10 mm Hg
GFR = Kf × NFP. Kf (filtration coefficient) is ENORMOUS here:
surface area ~1.5 m² over 2 million glomeruli, and a membrane
50–100× more permeable than a muscle capillary.
GFR ≈ 125 mL/min = 7.5 L/hour = 180 L/DAY filtered
URINE ≈ 1–2 L/day ⇒ more than 99% is reabsorbed
Plasma volume ≈ 3 L ⇒ your entire plasma is filtered ~60×/day
┌──────────────────────────────────────────────────────────────┐
│ WHY OP(cs) IS ZERO: the filtrate is protein-free, so there is │
│ no colloid osmotic pressure in Bowman's space to pull fluid │
│ out. If protein leaks — as in Amara — that term stops being │
│ zero, and filtration is subtly altered by the leak itself. │
└──────────────────────────────────────────────────────────────┘
Figure 26.5 — Net filtration pressure at the glomerulus, with the arithmetic.
Described: A diagram of the three Starling pressures acting across the glomerular capillary wall, drawn as stacked horizontal bands with arrows. The first and only outward force is glomerular hydrostatic pressure, the blood pressure inside the capillary tuft, at about 55 millimetres of mercury, pushing fluid out. Two inward forces oppose it: blood colloid osmotic pressure of about 30 millimetres of mercury, generated by plasma proteins that cannot cross the barrier and therefore pull fluid back in, and capsular hydrostatic pressure of about 15 millimetres of mercury, generated by filtrate already present in Bowman's space pushing back. Net filtration pressure is therefore 55 minus the sum of 15 and 30, which equals positive 10 millimetres of mercury. Glomerular filtration rate equals the filtration coefficient multiplied by net filtration pressure; the filtration coefficient is very large in the glomerulus because the total surface area is roughly 1.5 square metres across about two million glomeruli and the membrane is fifty to one hundred times more permeable than a skeletal muscle capillary. The resulting glomerular filtration rate is about 125 millilitres per minute, or 7.5 litres per hour, or 180 litres per day, against a urine output of one to two litres per day, meaning more than ninety-nine percent of the filtrate is reabsorbed; with a plasma volume near three litres, the entire plasma volume is filtered about sixty times a day. A boxed note explains that the colloid osmotic pressure of the capsular space is normally zero because the filtrate is protein-free, and that when protein leaks, as in Amara's case, that term ceases to be zero and filtration is itself altered by the leak.
A net pressure of only 10 mm Hg produces 180 litres a day. That should feel wrong until you look at the other term. GFR = K_f × NFP, and the kidney's trick is not pressure — it is K_f. Two million glomeruli present roughly a square metre and a half of a membrane that is far more permeable to water than any other capillary in the body. The kidney filters by having a preposterously large, preposterously leaky filter at modest pressure, not by squeezing hard.
That design has a consequence you should notice immediately: because NFP is only 10 mm Hg, small changes in any of the three pressures change GFR a great deal. A rise in capsular pressure of 10 mm Hg — from an obstructing stone, say — takes NFP to zero and stops filtration in that kidney entirely. A fall in glomerular pressure from 55 to 45, which is a 20% change, halves NFP and halves GFR. Filtration lives on a knife edge, which is why it needs the three-layer regulatory system that follows.
Regulation 1 · Renal autoregulation (intrinsic)
Between a mean arterial pressure of roughly 80 and 180 mm Hg, renal blood flow and GFR are held nearly constant by the kidney acting alone, with no nerves and no hormones. Two mechanisms share the work.
The myogenic mechanism. Vascular smooth muscle contracts when it is stretched. When arterial pressure rises, the afferent arteriole is distended, its smooth muscle depolarizes, voltage-gated calcium channels open, and it constricts — raising resistance upstream of the glomerulus and cancelling the pressure rise before it reaches the tuft. It responds within seconds and it is non-specific: it is the same mechanism that protects capillary beds in the brain.
Tubuloglomerular feedback (TGF). This one is unique to the kidney and is a beautiful negative feedback loop with all four of Chapter 1's boxes.
- Variable: this nephron's own GFR.
- Receptor: the macula densa, reading NaCl concentration in the fluid leaving the thick ascending limb. Higher GFR means faster tubular flow means less time for NaCl reabsorption upstream means higher NaCl at the macula densa.
- Control centre and signal: macula densa cells take up NaCl through NKCC2, swell, and release ATP, which is converted extracellularly to adenosine.
- Effector: adenosine acts on A1 receptors on the afferent arteriolar smooth muscle, constricting it — and simultaneously inhibits renin release from the granular cells.
- Result: afferent constriction lowers glomerular pressure, GFR falls back toward normal, NaCl at the macula densa falls, and the signal switches off.
Each nephron regulates itself. And the low-NaCl arm runs the other way: when macula densa NaCl is low, the afferent arteriole dilates and renin release is stimulated — which is precisely the arm that SGLT2 inhibitors exploit (§26.10).
Regulation 2 · Sympathetic control (extrinsic, and it overrides everything)
At rest, sympathetic tone to the kidney is low and autoregulation is in charge. Under stress — hemorrhage, shock, severe exercise, pain — the sympathetic nervous system takes over:
- α₁ receptors on afferent (and, less so, efferent) arterioles: vasoconstriction, falling renal blood flow, falling GFR. Blood is redirected to brain and heart. The kidney is deliberately sacrificed, exactly as skin was in Chapter 1.
- β₁ receptors on granular cells: renin release, which raises systemic blood pressure.
The kidney is thus both a victim of and a participant in the stress response. It gives up its own perfusion and, in the same act, helps restore the pressure of the circulation as a whole.
Regulation 3 · The renin–angiotensin–aldosterone system
You met the RAAS in Chapter 16 as an endocrine axis. Here it is as a renal one.
Three stimuli release renin, and note that all three are ways of detecting "not enough blood getting here":
- Reduced stretch of the granular cells (falling renal perfusion pressure) — a direct mechanoreceptor.
- Reduced NaCl at the macula densa — an indirect report of low GFR.
- β₁ sympathetic stimulation — the body's global judgement that pressure is low.
The cascade: renin (kidney) cleaves angiotensinogen (made by the liver, always in the plasma) to angiotensin I; angiotensin-converting enzyme (ACE), abundant on pulmonary capillary endothelium, converts it to angiotensin II. Renin is the rate-limiting step, which is why the kidney controls the whole system.
Angiotensin II does five things, and every one of them raises blood pressure:
| Action | Site | Effect |
|---|---|---|
| Systemic arteriolar vasoconstriction | All arterioles | ↑ peripheral resistance → ↑ MAP |
| Efferent arteriolar constriction | Kidney | Maintains glomerular pressure and GFR when perfusion falls |
| Direct stimulation of Na⁺ reabsorption | PCT (NHE3) | Salt and water retained |
| Stimulates aldosterone release | Adrenal zona glomerulosa | ENaC in collecting duct → more Na⁺ retained, K⁺ excreted |
| Stimulates ADH release and thirst | Hypothalamus | Water retained and water taken in |
The answer to Case File question 3
Now assemble it.
Amara's heart is failing, so renal perfusion is down, so her RAAS is chronically switched on (recall her plasma renin activity of 4.8 ng/mL/h and aldosterone of 22 ng/dL from Chapter 16). Angiotensin II is constricting her efferent arterioles. Her GFR is being propped up artificially by a squeeze on the outflow of every glomerulus. Her creatinine of 1.1 on admission was, in part, a number rescued by angiotensin II.
Add lisinopril. ACE is blocked, angiotensin II falls, the efferent arterioles dilate, glomerular hydrostatic pressure drops from perhaps 60 mm Hg back toward 50, NFP falls, and GFR falls with it. Creatinine rises from 1.1 to 1.4. The drug did exactly what it was supposed to do, and the rising creatinine is the evidence.
Why is this good? Because the pressure that was propping up her GFR was also destroying her glomeruli. Sustained intraglomerular hypertension stretches podocytes, which are terminally differentiated cells that cannot divide and cannot be replaced. Stretched podocytes efface their foot processes, detach, and are lost in the urine; the denuded basement membrane adheres to Bowman's capsule; mesangial cells respond to stretch and to angiotensin II by proliferating and laying down matrix; and the glomerulus sclerosis. Albumin leaking into the tubule is itself inflammatory, driving interstitial fibrosis. High glomerular pressure buys filtration today and spends nephrons to do it.
The clinical rule follows directly: a creatinine rise of up to about 30% after starting an ACE inhibitor or ARB, which stabilizes within two to four weeks, is expected, acceptable, and predicts better long-term kidney survival. Amara's rise from 1.1 to 1.4 is 27%. A larger or progressive rise means something else — most classically bilateral renal artery stenosis, where the efferent squeeze was the only thing maintaining filtration and removing it collapses the kidney. The other thing to watch is potassium: less aldosterone means less K⁺ excretion, and Amara is already at 4.9 mEq/L.
Clinical Connection · Diabetic Nephropathy, Stage by Stage
Diabetes is the leading cause of end-stage kidney disease worldwide, and its course is a sequence you can now read mechanistically.
| Stage | GFR | Albuminuria | What is happening structurally |
|---|---|---|---|
| 1 · Hyperfiltration | High — 130–150 | Normal | Hyperglycemia upregulates SGLT2, so more Na⁺ is reabsorbed proximally, so less NaCl reaches the macula densa, so tubuloglomerular feedback dilates the afferent arteriole. Glomerular pressure rises. |
| 2 · Silent | Normal | Normal | Basement membrane thickens; mesangial matrix expands. Creatinine is perfect. Years pass. |
| 3 · Moderately increased albuminuria (A2) | Normal to mildly reduced | ACR 30–300 mg/g | Loss of heparan sulfate charge; podocyte stress and early loss. Amara is here, at ACR 180. |
| 4 · Severely increased albuminuria (A3) | Falling | ACR > 300 mg/g | Podocyte depletion; Kimmelstiel–Wilson nodules; glomerulosclerosis. |
| 5 · Kidney failure | < 15 | Variable, may fall as filters are lost | Global sclerosis and interstitial fibrosis. |
Two features deserve emphasis. First, the earliest abnormality is a GFR that is too high, not too low — which no routine test looks for. Second, albuminuria appears years before creatinine moves, which is why annual ACR screening in diabetes is not optional. Amara's ACR was never measured until Chapter 26.
Treatment maps onto the mechanism: glycemic control removes the driver; RAAS blockade lowers glomerular pressure from the efferent side; SGLT2 inhibitors lower it from the afferent side by restoring macula densa NaCl delivery; blood pressure control lowers the pressure delivered to the glomerulus in the first place.
Check Your Understanding 26.4
- A stone lodges in the left ureter and capsular hydrostatic pressure rises from 15 to 40 mm Hg. Calculate the new NFP and state what has happened to that kidney's filtration.
- Why does severe hypoalbuminemia (say, blood colloid osmotic pressure falling from 30 to 18 mm Hg) increase GFR?
- A patient with heart failure and a marginal blood pressure is started on an NSAID for knee pain while already taking an ACE inhibitor and a diuretic. Predict what happens to their GFR and explain using both arterioles.
Show answers
- NFP = 55 − (40 + 30) = −15 mm Hg. The net pressure is now inward, so filtration in that kidney has stopped completely; this is obstructive, or postrenal, acute kidney injury. Because the other kidney is unaffected, the serum creatinine may barely move — which is exactly why unilateral obstruction can silently destroy a kidney over weeks.
- NFP = 55 − (15 + 18) = 22 mm Hg, more than double normal. The opposing oncotic force has been removed, so more fluid crosses. This is why nephrotic syndrome, liver failure, and severe malnutrition are associated with high filtration fractions of the remaining plasma — and it is also why they cause edema everywhere else, since the same lost oncotic pressure fails to hold fluid inside systemic capillaries (Chapter 19).
- GFR falls, potentially catastrophically. This is the classic "triple whammy." The diuretic reduces circulating volume, so renal perfusion pressure is low and the kidney depends on autoregulation. Autoregulation of the afferent arteriole in that setting depends heavily on locally produced vasodilator prostaglandins — and the NSAID blocks cyclooxygenase and abolishes them, so the afferent arteriole constricts. Meanwhile the ACE inhibitor has removed angiotensin II, so the efferent arteriole cannot constrict to compensate. Inflow restricted, outflow wide open: glomerular pressure collapses, and so does GFR. Each drug alone is usually fine. Together, in a volume-depleted patient, they are one of the commonest avoidable causes of acute kidney injury.
26.5 Tubular Reabsorption and Secretion, Segment by Segment
Filtration is indiscriminate: everything small enough goes. That means the kidney throws away, in the first step, 180 litres of water, 25,000 mEq of sodium, 180 g of glucose, and every amino acid in the plasma — every day. The tubule's job is to take back what was worth keeping, and it must take back over 99% of it.
Two directions of transport:
- Reabsorption — tubule lumen → tubular cell → interstitium → peritubular capillary.
- Secretion — peritubular capillary → tubular cell → tubule lumen. Secretion exists because filtration alone is not enough: it is a second chance to remove things, and it is the only route for substances that are protein-bound and therefore poorly filtered.
The engine: one pump powers almost everything
Before any segment, understand the power supply. On the basolateral membrane of essentially every tubular cell sits the Na⁺/K⁺ ATPase, pumping 3 Na⁺ out of the cell into the interstitium and 2 K⁺ in, burning one ATP per cycle. It does two things:
- It keeps intracellular sodium low — about 10–15 mEq/L against 140 mEq/L in the lumen.
- It keeps the cell interior electrically negative, about −70 mV.
Together those create a steep electrochemical gradient for sodium pointing into the cell across the apical membrane. Every apical transporter in the nephron is a device for spending that gradient:
| Apical transporter | Segment | What rides in on sodium's gradient |
|---|---|---|
| SGLT2, SGLT1 | PCT | Glucose |
| Na⁺–amino acid cotransporters | PCT | All 20 amino acids |
| NHE3 (Na⁺/H⁺ exchanger) | PCT | H⁺ out — which drives bicarbonate reclamation |
| NaPi-IIa | PCT | Phosphate |
| NKCC2 (Na⁺-K⁺-2Cl⁻) | Thick ascending limb | K⁺ and 2 Cl⁻ |
| NCC (Na⁺-Cl⁻) | DCT | Cl⁻ |
| ENaC (epithelial Na⁺ channel) | Collecting duct | Nothing — a pure channel, aldosterone-regulated |
Nothing on that list is directly powered by ATP. All of it is secondary active transport funded by one basolateral pump. Block that pump and every reabsorptive process in the nephron stops within minutes.
That is also why the kidney is, per gram, second only to the heart in ATP consumption — roughly 80% of renal oxygen use goes to sodium pumping — and it explains an important vulnerability. The thick ascending limb does the hardest pumping in the nephron, and it sits in the outer medulla, where the vasa recta have already given up much of their oxygen on the way down. High demand, marginal supply. When blood pressure falls, the outer medullary TAL is the first tissue in the kidney to die, which is why ischemic acute tubular necrosis damages that segment preferentially and sheds its cells into the urine as muddy-brown granular casts.
Segment by segment
WHAT HAPPENS WHERE ALONG THE NEPHRON (of the total FILTERED load)
┌─PCT────────────┬─LOOP──────────┬─DCT─────┬─COLLECTING DUCT──────┐
│ 65% Na+, H2O │ 25% Na+ │ 5–8% Na+│ ~3% Na+ (ENaC) │
│ 100% GLUCOSE │ (thick asc.) │ (NCC) │ WATER (AQP2) │
│ 100% AA │ 15% H2O │ Ca2+ ↑ │ K+ SECRETED (ROMK) │
│ 90% HCO3- │ (thin desc. │ by PTH │ H+ SECRETED (type A) │
│ 65% K+, 50% │ ONLY) │ │ UREA (UT-A1, ADH) │
│ urea, Ca2+, PO4│ Ca2+, Mg2+ │ │ │
├────────────────┼───────────────┼─────────┼──────────────────────┤
│ SECRETES: H+, │ SECRETES: — │ SECRETES│ SECRETES: K+, H+, │
│ NH4+, organic │ │ : K+, H+│ NH3/NH4+ │
│ acids & bases, │ │ │ │
│ creatinine(10%)│ │ │ │
│ drugs (OAT/OCT)│ │ │ │
├────────────────┼───────────────┼─────────┼──────────────────────┤
│ OBLIGATORY │ builds the │ FINE │ FULLY REGULATED │
│ not hormonal │ GRADIENT │ TUNING │ aldosterone · ADH · │
│ ISOSMOTIC │ │ thiazide│ ANP · acid-base │
│ │ │ target │ │
├────────────────┼───────────────┼─────────┼──────────────────────┤
│ fluid leaving: │ fluid leaving:│ leaving:│ leaving: 50–1200 │
│ 300 mOsm │ ~100 mOsm │ ~100 │ mOsm — YOUR CHOICE │
│ (isosmotic) │ (HYPOsmotic!) │ mOsm │ (ADH decides) │
└────────────────┴───────────────┴─────────┴──────────────────────┘
▲ ▲ ▲
DIURETIC TARGETS: acetazolamide (PCT) · LOOP diuretics (NKCC2,
thick ascending) · THIAZIDES (NCC, DCT) · amiloride & spironolactone
(ENaC / mineralocorticoid receptor, collecting duct)
Figure 26.6 — Reabsorption and secretion along the tubule, as fractions of the filtered load.
Described: A four-column table laid out along the length of the nephron, showing what each segment reabsorbs and secretes as a fraction of the filtered load. The proximal convoluted tubule reabsorbs 65 percent of sodium and water, 100 percent of glucose and amino acids, 90 percent of bicarbonate, 65 percent of potassium, and about half of the urea, calcium, and phosphate; it secretes hydrogen ion, ammonium, organic acids and bases, about ten percent of creatinine, and many drugs through organic anion and cation transporters. Its reabsorption is obligatory rather than hormonally regulated and is isosmotic, so the fluid leaving remains at about 300 milliosmoles. The loop of Henle reabsorbs 25 percent of sodium in its thick ascending limb and 15 percent of water in its thin descending limb only, plus calcium and magnesium; it secretes nothing and its function is to build the medullary gradient, and the fluid leaving it is hypo-osmotic at about 100 milliosmoles. The distal convoluted tubule reabsorbs 5 to 8 percent of sodium through the NCC cotransporter and raises calcium reabsorption under parathyroid hormone; it secretes potassium and hydrogen ion and performs fine tuning. The collecting duct reabsorbs about 3 percent of sodium through ENaC and water through aquaporin-2, secretes potassium through ROMK and hydrogen ion through type A intercalated cells, and moves urea through UT-A1 under ADH control; it is fully regulated by aldosterone, ADH, natriuretic peptides, and acid-base status, and the fluid leaving it ranges from 50 to 1200 milliosmoles depending on ADH. The four diuretic classes are marked at their target segments: acetazolamide at the proximal tubule, loop diuretics at NKCC2 in the thick ascending limb, thiazides at NCC in the distal convoluted tubule, and amiloride and spironolactone at ENaC and the mineralocorticoid receptor in the collecting duct.
Proximal convoluted tubule — the bulk absorber. Sixty-five percent of the filtered sodium and water, and 100% of the glucose and amino acids, are recovered here. Reabsorption is obligatory (not hormonally switched) and isosmotic: water follows sodium so closely through aquaporin-1 and between the cells that the fluid leaving the PCT has the same osmolality as the fluid entering — about 300 mOsm/kg — even though its volume has fallen by two-thirds. The PCT changes how much fluid there is, not what kind.
Descending thin limb. Aquaporin-1 makes it freely water-permeable; it has essentially no salt transporters. Water leaves, solute stays, and the fluid becomes progressively concentrated as it descends into the salty medulla — up to 1200 mOsm/kg at the hairpin.
Ascending limbs. Water permeability now drops to nearly zero, and salt starts leaving. In the thick ascending limb this is active: NKCC2 hauls in Na⁺, K⁺, and 2 Cl⁻, and much of the K⁺ leaks straight back into the lumen through ROMK. That K⁺ recycling makes the lumen about +8 mV positive, and that positive charge drives paracellular reabsorption of Ca²⁺ and Mg²⁺ — a detail that explains, in one stroke, why loop diuretics waste calcium and magnesium. Because salt leaves and water cannot, the fluid emerging is hypo-osmotic, around 100 mOsm/kg. The thick ascending limb is the diluting segment, and it dilutes whether or not you need dilute urine.
Distal convoluted tubule. NCC brings in Na⁺ and Cl⁻; PTH increases Ca²⁺ reabsorption through apical TRPV5 channels and basolateral exchange. Fine adjustment, small volumes.
Collecting duct — the regulated segment. Principal cells reabsorb Na⁺ through ENaC and secrete K⁺ through ROMK, both under aldosterone control, and reabsorb water through aquaporin-2 under ADH control. Type A intercalated cells secrete H⁺ with an H⁺-ATPase and return new bicarbonate to the blood. In the inner medulla, ADH also opens urea transporters. Only about 3% of the filtered sodium is handled here — but 3% of 25,000 mEq is 750 mEq, and that is the entire margin between health and edema.
Transport maximum, renal threshold, and Amara's glycosuria
Every carrier-mediated transporter has a finite number of copies. When they are all occupied, the transport rate plateaus at its transport maximum (Tm). For glucose, Tm is about 375 mg/min in an adult.
What arrives at the transporters is the filtered load:
FILTERED LOAD (mg/min) = GFR (mL/min) × plasma concentration (mg/mL)
The renal threshold is the plasma concentration at which the substance first appears in the urine. For glucose it is about 180 mg/dL — noticeably lower than the ~300 mg/dL that pure Tm arithmetic predicts, because nephrons are not identical. Some have a lower Tm than others, and those saturate first. This heterogeneity is called splay, and it means glucose starts leaking before the average nephron is anywhere near saturated.
Now Amara. On admission her fasting plasma glucose was 212 mg/dL (Chapter 16) and her urine dipstick read 2+ for glucose. With a GFR of about 125 mL/min:
filtered load = 125 mL/min × 2.12 mg/mL = 265 mg/min
265 mg/min is BELOW the Tm of 375 mg/min → transporters not fully saturated
265 mg/min is ABOVE the threshold load of ~225 mg/min (125 × 1.80)
→ the low-Tm nephrons ARE saturated
RESULT: glycosuria. Roughly 40 mg/min ≈ 57 g of glucose per day into the urine.
That escaping glucose is osmotically active and holds water in the tubule, causing an osmotic diuresis — the polyuria, nocturia, and thirst of uncontrolled diabetes. It is also 57 g of carbohydrate, about 230 kcal, being thrown away daily, which is part of why untreated type 1 diabetes causes weight loss despite hyperglycemia.
Here is the twist, and it is the most useful thing in this section. The renal threshold is not a property of the blood. It is a property of the filtered load, and filtered load depends on GFR. Amara's GFR is now 46 mL/min. At the same plasma glucose of 212 mg/dL:
filtered load = 46 mL/min × 2.12 mg/mL = 97 mg/min — far below threshold
→ NO glycosuria
As her kidneys fail, her urine will stop showing sugar even if her blood sugar does not improve. Urine glucose is a test that becomes less sensitive precisely as the patient becomes sicker. It is also a preview of Case File question 1: single measurements in the urine and the blood are both hostage to a GFR that nobody was measuring.
Secretion, and the creatinine footnote that matters
The proximal tubule secretes organic anions and cations through the OAT and OCT transporter families — the route by which penicillin, furosemide, methotrexate, uric acid, and many other compounds are cleared. It is a saturable, competitive system: two drugs using the same transporter block each other.
Creatinine is filtered and secreted, to the tune of about 10–15% of what appears in the urine. Three consequences follow:
- Creatinine clearance modestly overestimates true GFR, typically by 10–20%.
- Drugs that block the OCT2/MATE secretory pathway — trimethoprim, cimetidine, cobicistat, dolutegravir — raise serum creatinine by 0.1–0.3 mg/dL without changing GFR at all. The filter is fine; the back door has been shut.
- As GFR falls, secretion contributes a larger fraction of total creatinine excretion, so creatinine-based estimates become progressively less accurate in advanced disease.
Check Your Understanding 26.5
- Digoxin toxicity and ouabain both inhibit the Na⁺/K⁺ ATPase. Predict the effect on proximal tubular glucose reabsorption and justify each step.
- A patient's serum creatinine rises from 1.0 to 1.2 mg/dL two days after starting trimethoprim-sulfamethoxazole for a urinary infection. Their urine output is unchanged and they feel well. What has probably happened?
- Explain why loop diuretics cause hypocalcemia while thiazides cause hypercalcemia.
Show answers
- Glucose reabsorption stops. SGLT2 is a secondary active transporter: it carries glucose uphill only by letting sodium run downhill into the cell. That downhill gradient exists solely because the basolateral Na⁺/K⁺ ATPase keeps intracellular sodium low. Inhibit the pump, intracellular sodium rises toward luminal levels, the gradient collapses, SGLT2 stalls, and filtered glucose passes on down the tubule. The same argument applies to amino acids, phosphate, and NHE3-driven bicarbonate reclamation — which is why the pump is correctly called the engine of the nephron.
- Trimethoprim blocks the OCT2/MATE transporters that secrete creatinine in the proximal tubule. Less creatinine reaches the urine by that route, so serum creatinine rises even though filtration is unchanged. The clues are the small magnitude, the rapid onset, the stable urine output, and the well patient. It resolves when the drug stops. (The alternative — genuine interstitial nephritis from the sulfonamide — is real but usually comes with eosinophils, rash, and a larger rise.)
- Both effects follow from where calcium is reabsorbed. In the thick ascending limb, calcium crosses between the cells, driven by the lumen-positive voltage that K⁺ recycling through ROMK creates. Loop diuretics block NKCC2, so there is no K⁺ recycling, so the lumen-positive voltage disappears, so paracellular calcium reabsorption stops. Calcium is lost in the urine — hence hypocalcemia and hypercalciuria, and hence the use of loop diuretics in hypercalcemia. In the distal convoluted tubule, calcium crosses through the cells via TRPV5. Thiazides block NCC, which lowers intracellular sodium, which speeds the basolateral Na⁺/Ca²⁺ exchanger that pumps calcium out the back of the cell, which pulls more calcium in the front. Calcium is retained — hence mild hypercalcemia, and hence thiazides being used to prevent calcium stones.
26.6 The Countercurrent Mechanism
This is the hardest mechanism in the chapter. Build it in four moves and do not skip any.
The problem to be solved. Fluid arriving at the collecting duct is dilute — about 100 mOsm/kg, thanks to the diluting segment. Urine must sometimes be concentrated — up to 1200 mOsm/kg — so that water can be conserved. But no cell in the body can pump water. Water only moves down an osmotic gradient. So to concentrate urine, the kidney must first build a region of tissue saltier than the fluid it wants to concentrate, and then let water leave into it.
That region is the medulla, and the gradient runs from 300 mOsm/kg at the corticomedullary junction to 1200 mOsm/kg at the papilla. Everything below is about how it is built and how it is kept.
Predict This
A loop diuretic blocks NKCC2 in the thick ascending limb. Before reading on: besides losing sodium in the urine, what will happen to the patient's ability to concentrate urine, and why?
(Answer: it is abolished. NKCC2 is the single active step that deposits salt into the medullary interstitium. Block it and the 1200 mOsm gradient dissipates within hours, so even maximal ADH cannot draw water out of the collecting duct. This is why loop diuretics are such powerful diuretics — they attack both salt reabsorption and the concentrating machinery at once — and why they are used to treat the water retention of inappropriate ADH secretion.)
Move 1 · The single effect
The thick ascending limb pumps NaCl out of the tubule into the interstitium and is impermeable to water. Working alone, at any single horizontal level, it can build a difference of about 200 mOsm/kg between the fluid in its lumen and the interstitium outside it. That is the limit of what the transporter can do against a gradient, and it is called the single effect. Two hundred is not twelve hundred. On its own the single effect is useless.
Move 2 · Multiplication by counterflow
Now add flow, and add the descending limb running alongside in the opposite direction.
- The thick ascending limb pumps salt out — interstitium rises to 400, tubular fluid falls to 200.
- The descending limb is water-permeable and salt-impermeable, so it equilibrates with that 400 mOsm interstitium by losing water. Fluid in the descending limb becomes 400.
- Fresh 300 mOsm fluid pushes in from the PCT, shifting the whole column downward. The 400 mOsm fluid rounds the bend into the ascending limb.
- The ascending limb pumps again — 200 mOsm out of a fluid that is now 400, so the interstitium at that level goes higher still.
- Repeat, continuously, for a lifetime.
Counterflow converts a small transverse gradient into a large axial one. The 200 mOsm single effect is multiplied along the length of the loop until the tip of the medulla reaches 1200. This is why the mechanism is called a countercurrent multiplier, and why loop length determines maximum urine concentration: a longer loop allows more rounds of multiplication.
Move 3 · Urea recycling supplies half the gradient
Salt alone cannot account for 1200 mOsm/kg. At the papilla, roughly 600 mOsm/kg is NaCl and roughly 600 mOsm/kg is urea.
Urea gets there by a circuit that only makes sense once you see it whole. The PCT reabsorbs about half the filtered urea. The loop, DCT, and cortical collecting duct are urea-impermeable, so as water is withdrawn, urea in the tubular fluid becomes highly concentrated. Then, in the inner medullary collecting duct, ADH opens UT-A1 and UT-A3 urea transporters, and the now very-concentrated urea pours out into the inner medullary interstitium. From there some of it re-enters the thin limbs of the loop through UT-A2 and travels around again — hence recycling.
Urea is the ideal medullary osmole for a reason worth stating: it is a waste product that must be excreted anyway, and it is small enough to cross membranes readily, so parking it in the interstitium costs the kidney no additional energy. The kidney turned its own garbage into plumbing.
One counterintuitive consequence: people on very low-protein diets make less urea and concentrate their urine less well. Severe malnutrition impairs water conservation.
Move 4 · The vasa recta preserve what the loop built
A gradient built by tubules would be washed straight out by blood flow — unless the blood vessels were arranged to prevent it. They are.
The vasa recta are hairpin capillaries running down and back up alongside the loops. They are freely permeable to water and solute and use no energy at all. As a descending vessel goes deeper, it loses water and gains solute, so the blood inside it stays roughly in equilibrium with the tissue around it. As the ascending vessel comes back up through progressively less salty tissue, it regains water and loses solute. Blood leaves the medulla only slightly hyperosmotic, and the gradient survives.
This is a countercurrent exchanger — passive, not multiplying, merely conserving. Two further features matter: medullary blood flow is deliberately low (about 5–10% of renal blood flow) and slow, because fast flow would wash out the gradient regardless of the hairpin geometry. Raising medullary blood flow, as happens when arterial pressure rises sharply, does exactly that, and the resulting loss of concentrating power contributes to pressure natriuresis.
THE COUNTERCURRENT MULTIPLIER AND EXCHANGER, WITH THE GRADIENT
CORTEX LOOP OF HENLE VASA COLLECTING
══════════════════════════════════════════════RECTA═══DUCT═══════
desc │ asc (thick) ↓ │ ↑ │
300 mOsm ──────── 300│300 ──────────────── 300 │300 ── │ 100 ◄ dilute
│ ▲ NaCl OUT │ │ fluid
│ │ (active, NKCC2) │ │ arrives
── OUTER MEDULLA ─────┼──┼──────────────────────┼───────┼──────
│ │ │ │
600 mOsm ──────── 600│400 ◄─ 200 mOsm "single 600 │600 │ 600
│ ▲ effect" at every │ ▲
H2O│ │ horizontal level │ │ H2O
OUT▼ │ NaCl │ │ OUT
── INNER MEDULLA ─────┼──┼──────────────────────┼───────┼──────
│ │ │ │
900 mOsm ──────── 900│700 900│900 │ 900
│ ▲ │ ▲
H2O▼ │ │ │ UREA OUT
│ │ │ │ (UT-A1,
1200 mOsm ─────── 1200│1000 1200│1200│ ADH)
PAPILLA ╲__▼__╱ ╲__▼__╱ ▼ 1200 ◄
concentrated
══════════════════════════════════════════════════════════ urine out
GRADIENT COMPOSITION AT THE PAPILLA: ~600 mOsm NaCl + ~600 mOsm UREA
THE THREE COMPONENTS, EACH WITH ONE JOB
────────────────────────────────────────────────────────────────
MULTIPLIER (loop of Henle) ACTIVE. Uses ATP via NKCC2 to make a
200 mOsm single effect, multiplied by counterflow to 900.
UREA RECYCLING (inner CD) PASSIVE + ADH-gated. Supplies half the
osmoles at no extra energy cost.
EXCHANGER (vasa recta) PASSIVE. Hairpin geometry + slow flow
prevent the blood from washing the gradient away.
ADH ACTS HERE ─► V2 receptor (basolateral, principal cell)
→ Gs → cAMP → PKA → phosphorylates AQUAPORIN-2
→ AQP2 vesicles FUSE with the APICAL membrane
→ water exits into the gradient. Minutes.
No ADH → AQP2 endocytosed → duct waterproof → 50 mOsm
Figure 26.7 — The countercurrent multiplier, urea recycling, and the vasa recta exchanger, with medullary osmolality values.
Described: A vertical diagram spanning cortex at the top through outer medulla, inner medulla, and papilla at the bottom, with four parallel columns: the descending limb, the ascending limb, the vasa recta, and the collecting duct. Interstitial osmolality is marked on the left, rising from 300 milliosmoles per kilogram in the cortex through 600 in the outer medulla and 900 in the inner medulla to 1200 at the papilla. In the loop of Henle, the thick ascending limb actively pumps sodium chloride out through NKCC2, creating a 200 milliosmole difference between lumen and interstitium at every horizontal level — the single effect. The descending limb, permeable to water but not salt, loses water into that saltier interstitium, so its contents concentrate as it descends, reaching 1200 at the hairpin. Counterflow multiplies the 200 milliosmole transverse difference into a 900 milliosmole axial gradient. In the inner medullary collecting duct, ADH opens UT-A1 urea transporters so that concentrated urea moves into the interstitium, where it supplies about 600 of the 1200 milliosmoles at the papilla, the other 600 being sodium chloride. The vasa recta run as hairpins alongside, losing water and gaining solute on the way down and regaining water on the way up, so that blood leaves only slightly hyperosmotic and the gradient is not washed away; this exchange is entirely passive and depends on slow flow. Fluid entering the collecting duct is dilute at about 100 milliosmoles; if ADH is present, water leaves along the whole length into the gradient and urine emerges at up to 1200 milliosmoles. The mechanism of ADH is shown: it binds V2 receptors on the basolateral membrane of principal cells, activating Gs, cyclic AMP, and protein kinase A, which phosphorylates aquaporin-2 so that aquaporin-2-bearing vesicles fuse with the apical membrane within minutes; without ADH the channels are taken back into the cell and the duct is waterproof, allowing urine as dilute as 50 milliosmoles.
ADH puts the gradient to use
The gradient is a standing asset. Whether it is used depends on one hormone.
Antidiuretic hormone (ADH, vasopressin) is synthesized in the supraoptic and paraventricular nuclei of the hypothalamus and released from the posterior pituitary (Chapter 16). Its principal stimulus is plasma osmolality, detected by osmoreceptors near the anterior hypothalamus that respond to changes of as little as 1% — a threshold near 280–285 mOsm/kg. Its secondary stimulus is volume, via baroreceptors; that pathway needs a loss of roughly 8–10% of blood volume before it engages, but once it does it overrides osmolality entirely. (Remember that override. It is the reason for the hyponatremia of heart failure, and it appears again in §26.10 and in Chapter 31.)
ADH binds V2 receptors on the basolateral membrane of collecting duct principal cells → Gs → adenylate cyclase → cAMP → protein kinase A → phosphorylation of aquaporin-2 → cytoplasmic vesicles studded with AQP2 fuse with the apical membrane. Within minutes, a waterproof epithelium becomes water-permeable, water flows out into the medullary gradient, and urine concentrates. Withdraw ADH and the channels are retrieved by endocytosis.
Note the elegance: aquaporin-3 and -4 sit permanently in the basolateral membrane, so water that enters the cell always has an exit. The regulated step is the apical entry, and it is regulated by moving channels rather than by making them — which is why the response takes minutes rather than hours.
Two numbers close the section. The daily solute load to be excreted is roughly 600–900 mOsm. At a maximum urine concentration of 1200 mOsm/kg, the minimum obligatory urine volume is therefore about 500 mL/day — you cannot excrete your daily solute in less, no matter how dehydrated you are. At the other extreme, with ADH fully suppressed and urine at 50 mOsm/kg, the kidney can excrete more than 20 L/day. That range, a factor of forty, is the width of the water homeostasis window.
Check Your Understanding 26.6
- Why must the thick ascending limb be impermeable to water for the multiplier to work at all?
- A patient has central diabetes insipidus (no ADH). Their medullary gradient is intact. What is their urine osmolality and volume, and why does the intact gradient not help?
- Explain why a marathon runner who drinks large amounts of plain water during a race can end up with dangerously dilute blood even though their kidneys are healthy.
Show answers
- Because the single effect is a separation of salt from water. If water could follow the salt out of the ascending limb, the tubular fluid would stay isosmotic with the interstitium no matter how much salt was pumped, and no gradient could ever be established. Water impermeability is what converts salt transport into an osmotic difference. It is also what makes the segment the diluting segment, and the two facts are the same fact.
- Urine osmolality is very low — 50–100 mOsm/kg — and volume is enormous, often 10–15 L/day. The gradient does not help because water cannot reach it: without ADH there are no aquaporin-2 channels in the apical membrane of the collecting duct, so the epithelium is waterproof and the dilute fluid arriving from the thick ascending limb simply passes through to the bladder. The gradient is a pressure difference with the tap closed. This is also the clean distinction from nephrogenic diabetes insipidus, in which ADH is present but the receptor or the aquaporin fails, and from an osmotic diuresis, in which urine volume is high but osmolality is not low.
- Because water balance is not a kidney-strength problem, it is a rate problem. The maximum rate at which even a healthy kidney can excrete free water is roughly 0.7–1.0 L per hour, and exercise itself is a powerful non-osmotic stimulus to ADH release — through pain, nausea, and volume shifts — which lowers that ceiling further. A runner drinking 1.5 L per hour is therefore adding water faster than it can be removed. Plasma sodium falls, water moves into cells including brain cells, and the result is exercise-associated hyponatremia. See the Exercise sidebar in §26.7, and Chapter 31.
26.7 Regulating Water and Sodium — Two Separate Problems
Students merge water balance and sodium balance because both involve salt water and both are handled by the kidney. Separating them is the single most valuable conceptual move in renal physiology, and clinicians who do not make it misdiagnose patients.
Thread 2 · Homeostasis Is the Master Concept
| WATER balance | SODIUM balance | |
|---|---|---|
| Defended variable | Osmolality (275–295 mOsm/kg) — a concentration | Volume of extracellular fluid, and therefore blood pressure — an amount |
| Sensor | Hypothalamic osmoreceptors; sensitive to ~1% change | Baroreceptors (carotid, aortic, afferent arteriole), macula densa, atrial stretch receptors |
| Effectors | ADH (renal water permeability) and thirst | RAAS (retain Na⁺), ANP/BNP (excrete Na⁺), sympathetic tone, pressure natriuresis |
| Renal handling changed | How much water is reabsorbed, independent of solute | How much sodium is reabsorbed, with water following |
| Failure looks like | Hyponatremia or hypernatremia — a concentration disorder | Edema or hypovolemia — a volume disorder |
The two are only loosely coupled, and that is the point. Sodium is the dominant extracellular osmole, so where sodium goes, water follows — which is why total body sodium determines extracellular volume. But ADH moves water without moving sodium, which is why the ratio of water to sodium determines osmolality. One knob sets the amount; the other sets the concentration.
The clinical payoff, in one sentence: hyponatremia is almost never a salt problem. It is a water problem. Amara's heart failure will, in Chapter 31, produce a low serum sodium while she is carrying several extra litres of salt water, because baroreceptor-driven ADH is retaining water faster than aldosterone is retaining sodium. Total body sodium: high. Serum sodium concentration: low. Both true simultaneously, and neither is treated by giving salt.
Making dilute urine, and making concentrated urine
Dilute urine. Osmolality falls below about 280 mOsm/kg → osmoreceptors quiet → ADH secretion stops → aquaporin-2 is retrieved from the apical membrane → the collecting duct is waterproof. The 100 mOsm/kg fluid from the thick ascending limb passes through, and the DCT and collecting duct keep pulling NaCl out of it without water following. Urine can reach 50 mOsm/kg, up to 20 L/day.
Concentrated urine. Osmolality rises above about 285 mOsm/kg (or volume falls by ~10%) → ADH released → aquaporin-2 inserted → water leaves the collecting duct all the way down the medullary gradient → urine reaches 1200 mOsm/kg, as little as 500 mL/day. Thirst is triggered in parallel and is the more powerful of the two arms: the kidney can only slow losses, while drinking replaces them.
The four hormones and their segments
| Hormone | Source | Segment | Transporter or channel | Net effect |
|---|---|---|---|---|
| ADH (vasopressin) | Posterior pituitary (made in hypothalamus) | Collecting duct principal cells | Inserts AQP2 apically; also opens UT-A1 for urea | Water reabsorbed; urine concentrated; no sodium moved |
| Aldosterone | Adrenal zona glomerulosa | Late DCT + collecting duct principal cells | ↑ ENaC, ↑ basolateral Na⁺/K⁺ ATPase, ↑ ROMK | Na⁺ (and water) retained; K⁺ and H⁺ secreted; takes hours (gene transcription) |
| ANP / BNP | Atrial / ventricular myocardium, on stretch | Inner medullary collecting duct; also afferent and efferent arterioles | Closes Na⁺ channels; dilates afferent, constricts efferent | Na⁺ and water excreted; ↑ GFR; inhibits renin, aldosterone, and ADH — the RAAS's mirror image |
| PTH | Parathyroid glands | DCT (Ca²⁺); PCT (phosphate, vitamin D) | ↑ TRPV5; internalizes NaPi-IIa; activates 1α-hydroxylase | Ca²⁺ retained, phosphate excreted, calcitriol made |
Note how neatly the pairs oppose. Aldosterone retains sodium; ANP excretes it. ADH retains water; nothing actively excretes water except the absence of ADH. And PTH's two renal actions run in opposite directions for the two ions it manages, which is exactly what a calcium-defending hormone should do when phosphate would otherwise precipitate the calcium it just liberated.
Amara's aldosterone was 22 ng/dL in Chapter 16 — above range for a patient who was not volume-depleted. Her BNP, measured in Chapter 22, was elevated. Her body is running the retaining system and the excreting system at full power simultaneously, and the retaining system is winning. That contest is the cardiorenal syndrome, and §26.10 draws it.
Exercise & Sport · The Kidney During Hard Exercise, and Two Things It Puts in the Urine
Renal blood flow collapses. At rest the kidneys take 20–25% of cardiac output. During maximal exercise, sympathetic α₁ constriction drops renal blood flow to roughly 20–25% of its resting value — from about 1,100 mL/min to perhaps 250 mL/min — and the renal fraction of cardiac output falls to 1–2%, because cardiac output has simultaneously risen fivefold and is being spent on muscle. The kidney is deliberately sacrificed, exactly as skin is sacrificed in shock.
GFR, however, falls far less than blood flow does — typically 30% or less at maximal effort — because angiotensin II constricts the efferent arteriole and props up glomerular pressure. The filtration fraction rises sharply. This is the same rescue mechanism as in heart failure, running for an hour instead of a decade.
Exercise proteinuria. Up to 70–80% of athletes have detectable proteinuria after intense exercise. It has two components: a glomerular one (raised glomerular pressure plus a transient increase in permeability, so albumin appears) and a tubular one (the reduced peritubular perfusion saturates the megalin/cubilin retrieval system, so filtered low-molecular- weight proteins escape). It is benign and resolves within 24–48 hours. Practical rule: proteinuria found after exercise must be rechecked at rest before anyone calls it kidney disease. Nia, who runs marathons, has had a positive dipstick after a race and a clean one two days later.
Exercise hematuria — "athlete's pseudonephritis" — is equally common and equally benign. Contributions come from repeated bladder-wall impact in runners, footstrike hemolysis releasing free hemoglobin, and glomerular leak. It too must clear within days; blood in the urine that does not clear needs investigation regardless of how much the patient runs.
Rhabdomyolysis is the dangerous version. Unaccustomed eccentric or repetitive exercise, especially in heat or dehydration, can break down skeletal muscle and dump its contents into plasma: creatine kinase (often > 5,000 and sometimes > 100,000 U/L), potassium, phosphate, purines, and myoglobin. Myoglobin is 17.8 kDa — small enough to be freely filtered, unlike the 64 kDa hemoglobin tetramer, which is bound by haptoglobin and largely retained. Filtered myoglobin injures the kidney three ways: hypovolemia (litres of fluid sequester in the damaged muscle, so renal perfusion falls), direct tubular toxicity (heme iron catalyses free-radical damage), and cast formation (myoglobin precipitates with Tamm–Horsfall protein and obstructs tubules, worst in acidic, concentrated urine).
The bedside clue is a beautiful dissociation: the urine is tea-coloured and the dipstick is strongly positive for blood, but microscopy shows no red cells. The dipstick detects heme, and the heme here is myoglobin. Treatment is early, aggressive intravenous fluid — dilute the pigment, restore flow, keep urine flowing. Statins (Chapter 9), sickle cell trait, extreme heat, and some supplements all raise the risk.
Exercise-associated hyponatremia is the mirror-image emergency and is discussed in §26.6 and Chapter 31: too much plain water, plus non-osmotic ADH, in an athlete who has been told to "stay ahead of thirst." It is a water excess, not a salt deficit — the §26.7 distinction, with a body count. Current guidance for endurance events is to drink to thirst.
26.8 Renal Clearance and the Assessment of Function
The clearance concept
Renal clearance is the volume of plasma from which a substance is completely removed per minute. It is not a volume of urine and not an amount of substance — it is a virtual volume, and that abstraction is what makes it powerful.
U(x) × V
C(x) = ────────── U = urine concentration of x
P(x) V = urine flow rate (mL/min)
P = plasma concentration of x
If a substance is freely filtered and then neither reabsorbed nor secreted, everything that appears in the urine got there by filtration — so its clearance is the GFR.
| Marker | Filtered? | Reabsorbed? | Secreted? | Clearance equals | Value |
|---|---|---|---|---|---|
| Inulin | Freely | No | No | GFR exactly | ~125 mL/min |
| Creatinine | Freely | No | Slightly (10–15%) | GFR, overestimated 10–20% | ~120–140 mL/min |
| PAH | Freely | No | Almost completely | Renal plasma flow | ~600–625 mL/min |
| Glucose | Freely | Completely | No | Zero (below threshold) | 0 mL/min |
| Urea | Freely | ~50% | No | About half of GFR | ~65 mL/min |
The clearance ratio (C_x ÷ C_inulin) reads off the tubular handling of anything: less than 1 means net reabsorption, exactly 1 means neither, more than 1 means net secretion. That one comparison replaces a great deal of memorization.
Inulin is the gold standard, but it must be infused intravenously to a steady state, so it is a research and specialist tool (its modern equivalents are iohexol and iothalamate). PAH is cleared so completely in one pass — about 90% extraction — that it measures effective renal plasma flow. Creatinine is used everywhere for one reason: it is already in the patient.
Why creatinine is a late and insensitive marker — Case File question 1
Creatinine is produced at a nearly constant rate by the non-enzymatic breakdown of creatine phosphate in skeletal muscle. At steady state, production equals excretion:
production = GFR × P(creatinine)
production
⇒ P(cr) = ─────────────── a RECTANGULAR HYPERBOLA
GFR
Plasma creatinine is inversely proportional to GFR. That single equation explains everything Amara wants to know.
PLASMA CREATININE vs GFR — the hyperbola, and the blind range
P(cr)
mg/dL
8 ┤●
│ ●
6 ┤ ●
│ ●
4 ┤ ● HALF the GFR is lost in the FLAT part
│ ● of the curve, where creatinine barely
2 ┤ ●● moves and stays inside the reference
│ ●●●● interval.
1 ┤ ················●●●●●●●●●●●●●● ← upper limit of normal, 1.1
│ ▲ ▲
0 └──┬────┬────┬────┬────┬─┴──┬──┴─┬────
10 20 40 60 80 100 120 GFR (mL/min)
AMARA AMARA
today 3 yrs ago
Cr 1.4 Cr 0.9
GFR 46 GFR ~82
┌──────────────────────────────────────────────────────────────┐
│ THE ARITHMETIC OF THE BLIND RANGE │
│ GFR 120 → Cr 0.8 │ GFR 60 → Cr 1.4 │ GFR 20 → Cr 4.0 │
│ GFR 100 → Cr 0.9 │ GFR 40 → Cr 2.1 │ GFR 10 → Cr 8.0 │
│ GFR 80 → Cr 1.1 │ GFR 30 → Cr 2.8 │ GFR 5 → Cr 16.0 │
│ │
│ From GFR 120 to 60 — HALF the kidney — creatinine moves │
│ 0.6 mg/dL and never leaves the reference interval. │
│ From GFR 20 to 10 — a tenth as much real filtration lost — │
│ creatinine moves 4.0 mg/dL. │
│ │
│ PLUS: the reference interval itself (0.5–1.1) spans more │
│ than a TWOFOLD range of GFR. A "normal" creatinine is │
│ compatible with having lost half of everything. │
└──────────────────────────────────────────────────────────────┘
Figure 26.8 — The hyperbolic relationship between plasma creatinine and GFR, and the range in which creatinine is blind.
Described: A plotted curve of plasma creatinine in milligrams per decilitre on the vertical axis against glomerular filtration rate in millilitres per minute on the horizontal axis. The curve is a rectangular hyperbola: at high GFR it is almost flat and close to the horizontal axis, and as GFR falls below about 40 it rises steeply. A horizontal dashed line marks the upper limit of the normal reference interval at 1.1 milligrams per decilitre; the curve stays below it until GFR falls to roughly 60. Two points are marked on the curve for the patient Amara: three years ago, creatinine 0.9 with an estimated GFR of about 82, and today, creatinine 1.4 with an estimated GFR of 46. A boxed table gives paired values along the curve: GFR 120 with creatinine 0.8, GFR 100 with 0.9, GFR 80 with 1.1, GFR 60 with 1.4, GFR 40 with 2.1, GFR 30 with 2.8, GFR 20 with 4.0, GFR 10 with 8.0, and GFR 5 with 16.0. The accompanying text observes that losing half the kidney, from a GFR of 120 down to 60, moves creatinine only 0.6 milligrams per decilitre and never takes it outside the reference interval, whereas losing a tenth as much real filtration late in the disease, from GFR 20 to 10, moves creatinine by 4.0. It further notes that the reference interval itself, 0.5 to 1.1, spans more than a twofold range of GFR, so a creatinine reported as normal is compatible with having lost half of all kidney function.
Three separate effects conspire to make creatinine blind early:
- The hyperbola. Losing the first half of GFR moves creatinine within the reference interval. Losing the last quarter moves it enormously. The test is most sensitive exactly when the diagnosis is least useful.
- Renal reserve. A healthy person filters far more than they need. The proof is the living kidney donor: remove one kidney and GFR drops 50% overnight, then recovers to 70–75% of baseline within weeks as the remaining nephrons hypertrophy and raise their individual filtration rates. Donors' creatinines are usually normal. You can give away half your renal mass and keep a normal blood test.
- Compensatory hyperfiltration. The same adaptation that makes donation safe hides disease. When nephrons are lost to diabetes or hypertension, the survivors raise their single-nephron GFR. Total GFR is defended, creatinine stays flat — and the hyperfiltration is itself injurious, raising pressure in the surviving glomeruli and accelerating their loss. The compensation is the disease's accomplice.
For Amara specifically: her creatinine of 0.9 three years ago corresponded, by CKD-EPI, to an eGFR of roughly 82 mL/min/1.73 m² — already below normal for a 42-year-old, and quite possibly after a period of diabetic hyperfiltration in which her GFR was above 130 and her creatinine looked excellent. Today's 1.4 corresponds to 46. Measured filtration has fallen about 44%. The number of functioning nephrons has almost certainly fallen further than that, because the survivors are working harder than they should be.
So the honest answer to her question is: the creatinine did not fail to move. It moved exactly as an inverse function should. What failed was the assumption that a number inside a reference interval means an organ inside a normal state.
eGFR equations, and their limits
Because creatinine depends on muscle mass as well as GFR, estimating equations adjust for the demographic determinants of muscle. The current standard is CKD-EPI 2021, which uses serum creatinine, age, and sex (the 2021 revision removed the race coefficient). For Amara — 45, female, creatinine 1.4 — it returns 46 mL/min/1.73 m².
Where it goes wrong is exactly where muscle mass is unusual: it overestimates GFR in cachexia, amputation, cirrhosis, paralysis, and advanced age, and underestimates it in bodybuilders and after a high-meat meal. Cystatin C, a protein produced by all nucleated cells at a rate largely independent of muscle, is the alternative, and a combined creatinine–cystatin C equation is the most accurate estimate available without an infusion.
CKD staging (KDIGO) uses GFR and albuminuria together, because they predict outcome independently:
| GFR category | GFR | Albuminuria category | ACR | |
|---|---|---|---|---|
| G1 | ≥ 90 | A1 normal to mildly increased | < 30 mg/g | |
| G2 | 60–89 | A2 moderately increased | 30–300 mg/g | |
| G3a | 45–59 | A3 severely increased | > 300 mg/g | |
| G3b | 30–44 | |||
| G4 | 15–29 | |||
| G5 | < 15 (kidney failure) |
Amara is G3a A2. Two people with identical eGFRs of 46 have very different futures if one has an ACR of 10 and the other 180; albuminuria roughly doubles to quadruples the risk of progression and of cardiovascular death. It is the better early marker precisely because it reports on the filtration barrier rather than on the filtration rate.
Urinalysis: what each finding means
| Finding | Normal | What an abnormal result implies |
|---|---|---|
| Specific gravity | 1.001–1.035 | A direct readout of concentrating ability. Fixed around 1.010 (isosthenuria) means the tubules can neither concentrate nor dilute — advanced CKD |
| pH | 4.5–8.0 | Persistently alkaline urine with infection suggests urea-splitting organisms and struvite stones |
| Protein (dipstick) | Negative | Detects albumin only above ~300 mg/day. Insensitive to A2 albuminuria — which is why ACR exists |
| Glucose | Negative | Filtered load has exceeded threshold (§26.5), or SGLT2 is pharmacologically blocked |
| Ketones | Negative | Fat oxidation dominant: fasting, low-carbohydrate diet, diabetic ketoacidosis |
| Blood / heme | Negative | Positive with red cells = bleeding. Positive without red cells = myoglobin or free hemoglobin |
| Nitrite | Negative | Enterobacteriaceae reduce dietary nitrate to nitrite; a positive is fairly specific for infection but insensitive |
| Leukocyte esterase | Negative | White cells in urine — infection or inflammation |
| Bilirubin / urobilinogen | Negative / trace | Hepatobiliary disease |
Then the microscope, where casts are the prize. A cast is a cylindrical mold of a tubule lumen, formed when Tamm–Horsfall (uromodulin) protein secreted by the thick ascending limb gels around whatever is in the tubule. Because casts can only form in a tubule, a cast proves the finding came from the nephron and not from the bladder or urethra — which is a diagnostic gift.
| Cast | Contains | Means |
|---|---|---|
| Hyaline | Protein only | Normal, especially in concentrated urine or after exercise |
| Red cell | Erythrocytes | Glomerulonephritis — bleeding from the glomerulus itself |
| White cell | Leukocytes | Pyelonephritis or interstitial nephritis |
| Muddy-brown granular | Degenerating tubular cells | Acute tubular necrosis — the outer medulla shedding |
| Waxy / broad | Degenerated material in dilated tubules | Advanced chronic disease |
Imaging · Ultrasound Answers the One Question That Matters First
When creatinine is high, the first question is not why but how long — acute or chronic — because that decides whether anyone is trying to reverse it. Renal ultrasound answers it in minutes, without radiation or contrast.
What it measures. Length (normal 9–13 cm), cortical thickness, corticomedullary differentiation, and echogenicity — how brightly the tissue reflects sound. Normal renal cortex is darker (less echogenic) than adjacent liver or spleen, because healthy tissue is mostly water and cells.
The chronic kidney. A small (< 9 cm), echogenic kidney with a thin cortex and loss of corticomedullary differentiation is scarred. Fibrous tissue has many acoustic interfaces and scatters sound, so scar is bright. That single image says: this took years, it will not reverse, and a biopsy will show fibrosis rather than a treatable lesion. (The important exceptions — kidneys that stay large despite chronic disease — are diabetes early on, amyloidosis, HIV-associated nephropathy, and polycystic disease.)
Hydronephrosis. Dilated calyces and pelvis appear as a dark branching space — obstruction until proven otherwise, and the whole reason ultrasound is mandatory in unexplained AKI, since postrenal failure is the one type that is reversed with a catheter or a stent.
Non-contrast CT is the standard for stones: it finds more than 99% of them, including uric acid stones that are invisible on plain radiographs, because CT measures density directly rather than relying on calcium content. CT urography adds intravenous contrast in timed phases — nephrographic to show the parenchyma, excretory to opacify the collecting system — and is the study for unexplained hematuria and urothelial tumors.
The caution. Iodinated contrast carries a risk of contrast-associated AKI, especially in patients who are already volume-depleted and already have reduced GFR — Amara's exact profile, and the reason her catheterization in Chapter 18 was done with a minimized contrast load and pre-hydration. In advanced CKD, gadolinium for MRI has its own historical association with nephrogenic systemic fibrosis, though newer agents have made this rare.
Aging · Why Adwoa Dehydrates So Easily
After about age 40, GFR falls by roughly 0.8–1.0 mL/min/1.73 m² per year — about 1% annually. Combined kidney mass falls from around 400 g in youth toward 300 g by the eighties. Up to 30% of glomeruli are globally sclerotic by age 80. None of this is disease; it is the baseline against which disease is measured.
Three functional consequences matter at the bedside, and Adwoa Mensah at 78 has all three.
1 · Concentrating ability is lost first. Maximum urine osmolality falls from ~1200 to ~700–800 mOsm/kg — medullary structure degrades, and collecting ducts respond less well to ADH. Diluting ability falls too. The operating range narrows at both ends: an older person cannot conserve water efficiently and cannot excrete a water load efficiently. They dehydrate easily and they flood easily.
2 · Thirst is blunted. The osmoreceptor–thirst pathway becomes less sensitive, so the more powerful of the two water-defence arms weakens exactly when the renal arm has weakened. A febrile illness, a hot day, or a diuretic can produce clinically significant dehydration before the person feels thirsty at all.
3 · Creatinine lies more, not less. Creatinine production is proportional to muscle mass, and Adwoa has lost muscle. A creatinine of 1.0 mg/dL in her corresponds to a GFR near 45–50 — the same territory as her daughter's — while looking entirely normal on the printout. Drug doses calculated from a normal-looking creatinine are the commonest source of iatrogenic harm in older patients, and it is why eGFR, not creatinine, must be used for dosing.
Add the blunted renin, aldosterone, and ANP responses of age, and the picture is complete: a narrower homeostatic window, defended by slower machinery, in a person less likely to notice. This is why the "triple whammy" of NSAID plus ACE inhibitor plus diuretic (§26.4) causes acute kidney injury so much more readily at 78 than at 45.
Check Your Understanding 26.8
- A substance has a clearance of 200 mL/min in a patient whose inulin clearance is 120 mL/min. What is the tubule doing to it?
- A 78-year-old woman and a 25-year-old male weightlifter both have a serum creatinine of 1.3 mg/dL. Whose kidney function is worse, and why?
- Amara's ACR is 180 mg/g but her dipstick reads only "trace" protein. Explain the discrepancy and say which result should guide management.
Show answers
- The clearance ratio is 200/120 = 1.67, which is greater than 1, so more of the substance is appearing in the urine than filtration alone could deliver. The tubule must be secreting it. (Anything with a ratio above 1 is secreted; PAH, at a ratio near 5, is the extreme case.)
- The 78-year-old's function is far worse. Creatinine is a balance between production, which depends on muscle mass, and clearance, which depends on GFR. The weightlifter produces a great deal of creatinine, so a value of 1.3 is compatible with an entirely normal GFR. The older woman produces little, so the same value implies a substantially reduced GFR — perhaps 35–40. Applying an eGFR equation, which adjusts for age and sex, makes the difference explicit; a cystatin C measurement would make it unambiguous.
- The dipstick's protein pad is insensitive: it detects albumin reliably only above roughly 300 mg/day, which is the A3 threshold. Amara is at about 180 mg/day — genuinely abnormal, six times normal, and prognostically important, but below what the pad can register. The ACR should guide management. This is precisely why guidelines specify a quantitative albumin-to-creatinine ratio rather than a dipstick for screening people with diabetes or hypertension. Using the creatinine ratio rather than a raw concentration also corrects for how dilute the sample was, which is why a spot sample works at all.
26.9 Micturition
Urine is produced continuously and voided intermittently, so the bladder is a reservoir with a gate — and the gate is under two kinds of control at once.
Storage. As the bladder fills, sympathetic outflow (T11–L2, via the hypogastric nerve) relaxes the detrusor through β₃ receptors and contracts the internal urethral sphincter through α₁ receptors. Simultaneously, somatic motor neurons in Onuf's nucleus (S2–S4) keep the external urethral sphincter — skeletal muscle — tonically contracted through the pudendal nerve. The bladder is remarkably compliant: pressure barely rises from 0 to 300 mL, because the detrusor's smooth muscle exhibits stress relaxation.
Voiding. Stretch receptors in the detrusor begin firing at about 150–300 mL, sending afferents through the pelvic nerves to the sacral cord. The reflex arc is there — but in a continent adult it is gated by the pontine micturition centre, which is itself under prefrontal cortical control. Voiding happens when the cortex permits it. Then:
- Parasympathetic outflow (S2–S4, pelvic splanchnic nerves) releases ACh onto M3 receptors → detrusor contracts.
- Sympathetic outflow falls → internal urethral sphincter opens.
- Voluntary relaxation of the external urethral sphincter → urine flows.
- Flow through the urethra stimulates further afferents, reinforcing detrusor contraction — a positive feedback loop, with the emptying of the bladder as its built-in endpoint. It belongs on Chapter 1's short list alongside clotting, labor, and the action potential.
Volumes to remember: first sensation ~150 mL; definite urge 300–400 mL; comfortable capacity 400–600 mL; painful above 600 mL.
Where it fails:
| Problem | Mechanism | Typical setting |
|---|---|---|
| Stress incontinence | Pelvic floor and urethral support weakened; a cough raises abdominal pressure faster than the sphincter can respond | Post-partum; post-menopausal loss of estrogen support (Chapter 27) |
| Urge incontinence | Detrusor overactivity — involuntary contractions during filling | Aging, neurological disease; treated with antimuscarinics or β₃ agonists |
| Overflow incontinence | Bladder cannot empty; it leaks when full | Obstruction (prostatic enlargement) or detrusor underactivity (diabetic autonomic neuropathy — a risk for Amara) |
| Neurogenic bladder | Lesion above the pons: loss of voluntary gating, so the spinal reflex runs unchecked. Lesion at or below S2–S4: areflexic, flaccid bladder | Spinal cord injury, multiple sclerosis, diabetic cystopathy |
Two practical notes. Urinary stasis is the enemy: whatever the cause, urine that sits is urine that grows bacteria and precipitates crystals, which is why obstruction, retention, and catheters all raise infection risk. And timing a diuretic matters: Amara takes furosemide in the morning, not the evening, because the peak diuresis arrives one to two hours after the dose and lasts about six — an evening dose buys a night of nocturia, and nocturia in a 45-year-old working nights is a compliance problem waiting to happen.
Clinical Connection · Kidney Stones, and Why the Pain Moves
About 80% of kidney stones are calcium oxalate. Stones form when urine becomes supersaturated and inhibitors of crystallization — chiefly citrate, which chelates calcium — are outmatched. Every risk factor is a version of that sentence: low urine volume, high urinary calcium, high oxalate, low citrate, and, for uric acid stones, persistently acidic urine.
Where they lodge is pure anatomy: the three ureteric narrowings of §26.1 — ureteropelvic junction, pelvic brim, ureterovesical junction. Stones under 5 mm pass spontaneously about 90% of the time; over 8 mm, rarely.
The pain is one of the best illustrations of Chapter 11's referred-pain principle. It is colicky — waves that crescendo and ease — because the ureter is peristalsing against an obstruction. It begins in the flank (T11–L1 visceral afferents) and, as the stone descends, migrates toward the groin, the labia or the scrotum, and the inner thigh, because the lower ureter's afferents enter the cord at the levels that also supply those dermatomes. The pain literally maps the stone's progress down the ureter, and an experienced clinician can estimate the stone's position from the patient's description alone.
Prevention is a set of directly mechanistic instructions: drink enough to produce more than 2.5 L of urine a day (dilution is the primary defence); restrict sodium, because sodium and calcium are co-reabsorbed in the proximal tubule, so a high salt intake drives calcium into the urine; add citrate; and — the counterintuitive one — do not restrict dietary calcium. Calcium eaten with a meal binds oxalate in the gut and prevents its absorption. Restricting dietary calcium leaves more free oxalate to be absorbed and excreted, and makes oxalate stones more likely. A thiazide diuretic is prescribed for recurrent calcium stones precisely because of the DCT mechanism in §26.5: it increases calcium reabsorption and lowers urinary calcium.
Clinical Connection · Urinary Tract Infection, and the Anatomy Behind the Sex Difference
Almost all urinary infection is ascending: organisms from the perineum colonize the distal urethra, climb to the bladder (cystitis), and occasionally continue up a ureter to the kidney (pyelonephritis). Escherichia coli causes 75–85% of uncomplicated cases, using P fimbriae to adhere to urothelial receptors against the flow.
Why women get many times more. Four anatomical and physiological reasons, and none of them is hygiene:
- A 3–4 cm urethra versus 18–20 cm. The journey is short.
- The meatus sits close to the vaginal introitus and the anus, so the starting inoculum is large.
- Intercourse mechanically inoculates the urethra — the basis of post-coital prophylaxis and of the advice to void afterward.
- After menopause, estrogen loss changes the vaginal ecosystem (Chapter 27): glycogen in the epithelium falls, lactobacilli decline, vaginal pH rises from about 4 toward 6, and uropathogens colonize more readily. This is why recurrent UTI is common in older women and why topical vaginal estrogen reduces recurrence.
Men are protected by urethral length, by a drier meatus, and by antibacterial prostatic secretions — so a UTI in a man is by definition complicated and prompts a search for obstruction, stones, or prostatic disease.
The defence that matters most is flow. Urine is normally sterile and is flushed out several times a day; the ureterovesical tunnel prevents reflux; and urothelium sheds infected cells. Anything that stops flow — a stone, an enlarged prostate, a neurogenic bladder, a catheter — removes the primary defence, which is why catheter-associated UTI is the commonest healthcare- associated infection.
Reading the presentation. Dysuria, frequency, urgency, and suprapubic discomfort with a positive leukocyte esterase and nitrite means cystitis. Add fever, rigors, flank pain, and costovertebral angle tenderness, and the infection has reached the kidney: pyelonephritis is a parenchymal infection with bacteremic potential, treated with a different drug class, for longer, and sometimes in hospital. White cell casts, if present, confirm the renal origin — the cast proves the cells came from a tubule.
26.10 Advanced Topic · The Cardiorenal Syndrome, Kidney Injury, and Diuretics
The loop that closes the book's central argument
Twenty-one chapters ago, Amara arrived with chest pain. The heart was the sick organ. Nothing was wrong with her kidneys. Six weeks after her infarct she has stage 3a chronic kidney disease, and the reason is not that a second disease happened to her. It is that the heart and the kidney share one control system, and neither can fail alone.
THE CARDIORENAL LOOP · every arrow is a mechanism
┌──────────────────────────────────────────────────────────┐
│ │
▼ │
╔══════════════════╗ │
║ ↓ CARDIAC OUTPUT ║ Amara: HFpEF — a stiff ventricle that │
║ (heart failure)║ cannot fill, so stroke volume is limited │
╚════════╤═════════╝ │
│ ↓ arterial pressure sensed by carotid, aortic and │
│ afferent-arteriolar baroreceptors as "low volume" │
▼ │
╔════════════════════════╗ ╔══════════════════════════════╗ │
║ ↓ RENAL PERFUSION ║ ║ ↑ SYMPATHETIC OUTFLOW ║ │
║ (forward flow falls) ║◄────►║ α1 vasoconstriction ║ │
╚════════╤═══════════════╝ ║ β1 → RENIN release ║ │
│ ╚════════════╤═════════════════╝ │
│ ALSO: ↑ central venous pressure │ │
│ → ↑ RENAL VENOUS pressure │ │
│ → ↓ perfusion GRADIENT and ↑ │ │
│ renal interstitial pressure │ │
│ (VENOUS congestion matters as │ │
│ much as forward flow) │ │
▼ ▼ │
╔═══════════════════════════════════════════════════════════════╗ │
║ RAAS ACTIVATED ║ │
║ renin → angiotensin I → [ACE] → ANGIOTENSIN II → ALDOSTERONE ║ │
╚═══╤═══════════════╤═══════════════╤═══════════════╤═══════════╝ │
│ │ │ │ │
▼ ▼ ▼ ▼ │
┌──────────┐ ┌─────────────┐ ┌────────────┐ ┌──────────────┐ │
│ EFFERENT │ │ ↑ PCT Na+ │ │ ALDO → ENaC│ │ SYSTEMIC │ │
│ARTERIOLAR│ │ reabsorption│ │ in collect-│ │ VASOCON- │ │
│CONSTRIC- │ │ (direct, + │ │ ing duct │ │ STRICTION │ │
│TION │ │ ↑ oncotic │ │ + ADH via │ │ │ │
│→ GFR │ │ pressure │ │ thirst/ │ │ │ │
│ propped │ │ from ↑ FF) │ │ baroreflex │ │ │ │
│ up │ └──────┬──────┘ └─────┬──────┘ └──────┬───────┘ │
└────┬─────┘ │ │ │ │
│ ▼ ▼ │ │
│ ╔════════════════════════════╗ │ │
│ ║ Na+ AND WATER RETENTION ║ │ │
│ ╚═════════════╤══════════════╝ │ │
│ ▼ ▼ │
│ ╔═══════════════════════╗ ╔═══════════════════╗ │
│ ║ ↑ BLOOD VOLUME ║ ║ ↑ AFTERLOAD ║ │
│ ║ ↑ PRELOAD ║ ║ (harder to eject) ║ │
│ ║ → pulmonary and ║ ╚═════════╤═════════╝ │
│ ║ peripheral EDEMA ║ │ │
│ ║ → in a STIFF ventricle,│ │ │
│ ║ small volume = big ║ │ │
│ ║ pressure rise ║ │ │
│ ╚═══════════╤═══════════╝ │ │
│ └──────────┬─────────────┘ │
│ ▼ │
│ ╔════════════════════════════════╗ │
│ ║ ↑ MYOCARDIAL WALL STRESS and ║ │
│ ║ ↑ OXYGEN DEMAND → ↓ STROKE ║────────────┘
│ ║ VOLUME → ↓ CARDIAC OUTPUT ║ LOOP CLOSES
│ ╚════════════════════════════════╝ (POSITIVE
│ FEEDBACK)
│ and meanwhile, chronically:
└─► sustained HIGH GLOMERULAR PRESSURE → podocyte injury →
ALBUMINURIA → interstitial inflammation → NEPHRON LOSS →
less kidney → worse volume control → worse heart. (2nd loop)
══════════════════════════════════════════════════════════════════
THE OPPOSING SYSTEM: stretched atria and ventricles release ANP and
BNP, which excrete Na+, dilate the afferent arteriole, and inhibit
renin, aldosterone and ADH. In chronic heart failure the RAAS
OVERWHELMS them ("natriuretic peptide resistance") — which is why
BNP is a good MARKER of the loop and a poor BRAKE on it.
WHERE DRUGS CUT THE LOOP
ACE inhibitor / ARB ──────► blocks angiotensin II (both arms)
Beta-blocker ─────────────► blocks β1 renin release + sympathetic
MRA (spironolactone) ─────► blocks aldosterone at the receptor
Loop diuretic ────────────► removes the retained volume (preload)
SGLT2 inhibitor ──────────► natriuresis + restores tubuloglomerular
feedback → afferent constriction
ARNI (sacubitril) ────────► blocks breakdown of ANP/BNP: helps the
opposing system instead of blocking RAAS
Figure 26.9 — The cardiorenal loop, with every mechanism labeled and every drug target marked.
Described: A closed feedback diagram beginning with reduced cardiac output from heart failure — in Amara's case a stiff ventricle that cannot fill. Falling arterial pressure is detected by carotid, aortic, and afferent arteriolar baroreceptors as low volume, which produces two parallel consequences: reduced renal perfusion, and increased sympathetic outflow causing alpha-one vasoconstriction and beta-one mediated renin release. A side branch notes that raised central venous pressure also raises renal venous pressure, reducing the perfusion gradient across the kidney and raising renal interstitial pressure, so venous congestion impairs filtration as much as reduced forward flow does. Both paths converge on activation of the renin-angiotensin-aldosterone system: renin converts angiotensinogen to angiotensin one, ACE converts that to angiotensin two, and angiotensin two stimulates aldosterone. Four effects follow. First, efferent arteriolar constriction props up glomerular filtration. Second, proximal tubular sodium reabsorption rises, both directly and because a higher filtration fraction raises peritubular oncotic pressure. Third, aldosterone opens ENaC channels in the collecting duct while ADH, released through the baroreflex, retains water. Fourth, systemic vasoconstriction raises afterload. The middle three produce sodium and water retention, which raises blood volume and preload, causing pulmonary and peripheral edema — and in a stiff ventricle a small volume increase produces a large pressure increase. Raised preload and raised afterload together increase myocardial wall stress and oxygen demand, reducing stroke volume and therefore cardiac output, which closes the loop as positive feedback. A second, slower loop is drawn: sustained high glomerular pressure injures podocytes, producing albuminuria and interstitial inflammation and progressive nephron loss, which worsens volume control and therefore the heart. A note explains that stretched atria and ventricles release the natriuretic peptides ANP and BNP, which oppose every arm of the loop but are overwhelmed in chronic heart failure, making BNP a good marker of the loop and a poor brake on it. The final panel lists where drugs cut the loop: ACE inhibitors and ARBs block angiotensin two; beta-blockers block sympathetic drive and renin release; mineralocorticoid receptor antagonists block aldosterone; loop diuretics remove retained volume; SGLT2 inhibitors cause natriuresis and restore tubuloglomerular feedback so the afferent arteriole constricts; and ARNI drugs block the breakdown of ANP and BNP, strengthening the opposing system rather than blocking the RAAS.
Two features of that diagram deserve to be said out loud.
First, every single arrow is a normal, adaptive mechanism. Nothing in the loop is a malfunction. The baroreflex, renin release, efferent constriction, aldosterone, ADH — all of them are exactly the responses that save a person who is bleeding. The problem is that the sensors cannot tell the difference between not enough blood and not enough pumping. Heart failure presents the body with low arterial pressure and full veins, and the body reads only the first half. This is Chapter 1's point about context-blind reflexes, in its most consequential form.
Second, this is why heart failure is treated with drugs that seem to weaken the heart. ACE inhibitors, beta-blockers, and mineralocorticoid antagonists do not make the myocardium stronger. They interrupt the loop. The mortality benefit of every one of them comes from blocking a compensation, not from adding a compensation — and that is only sensible if you can see the loop.
Cardiorenal syndrome is formally classified in five types by which organ fails first and how fast: type 1, acute heart failure causing acute kidney injury; type 2, chronic heart failure causing chronic kidney disease — Amara; type 3, acute kidney injury causing acute cardiac dysfunction; type 4, chronic kidney disease causing chronic cardiac disease; type 5, a systemic insult such as sepsis damaging both.
Acute kidney injury: three places the problem can be
AKI is defined by KDIGO as a rise in creatinine of ≥0.3 mg/dL within 48 hours, or ≥1.5× the baseline within 7 days, or urine output below 0.5 mL/kg/h for 6 hours. Localizing it is the whole of the initial workup, and there are only three possible locations.
| Prerenal (~60%) | Intrinsic (~35%) | Postrenal (~5%) | |
|---|---|---|---|
| Problem | Not enough blood arriving | The kidney tissue itself is damaged | Urine cannot get out |
| Causes | Hypovolemia, heart failure, sepsis, renal artery stenosis, NSAID/ACEi/diuretic triple whammy | Acute tubular necrosis (ischemia, contrast, aminoglycosides, myoglobin); glomerulonephritis; interstitial nephritis | Prostatic enlargement, bilateral stones, pelvic tumor, blocked catheter |
| Tubules | Intact and desperate — reabsorbing every sodium ion | Damaged — cannot reabsorb | Initially intact, then damaged by back-pressure |
| Urine sodium | < 20 mEq/L | > 40 mEq/L | Variable |
| FE_Na | < 1% | > 2% | Variable |
| Urine osmolality | > 500 (concentrating hard) | ~300 (isosthenuric) | Variable |
| BUN : creatinine | > 20 : 1 (urea follows reabsorbed sodium and water) | ~10–15 : 1 | Variable |
| Sediment | Bland, or hyaline casts | Muddy-brown granular casts (ATN); RBC casts (GN); WBC casts and eosinophils (AIN) | Bland |
| Reversible? | Yes, quickly — restore perfusion | Partly, over days to weeks | Yes, if relieved promptly |
The logic behind the whole table is one sentence: a prerenal kidney is a healthy kidney behaving correctly in bad circumstances, so it does everything it can to hold on to salt and water. A kidney with dead tubules cannot do those things, so its urine looks like plasma filtrate. Read the urine, and it tells you whether the tubules still work.
Note the trap in the middle column: prerenal injury, if it persists, becomes acute tubular necrosis. The outer medullary thick ascending limb, with its huge ATP demand and marginal oxygen supply (§26.5), dies first — and the muddy-brown casts in the urine are literally those cells.
Clinical Connection · Acute or Chronic? The Single Most Useful Test Is an Old Result
Distinguishing acute kidney injury from chronic kidney disease determines everything that happens next, and it is not always obvious at the bedside. Five discriminators:
| Feature | Favours acute | Favours chronic |
|---|---|---|
| Previous creatinine | Normal weeks ago | Elevated for months or years |
| Kidney size on ultrasound | Normal or large | Small, echogenic, thin cortex |
| Anemia | Usually absent | Present — EPO has been failing for months |
| Calcium and phosphate | Usually normal | Low calcium, high phosphate, high PTH — takes months to develop |
| Symptoms | Often abrupt: oliguria, the precipitating illness | Insidious: fatigue, nocturia, pruritus, often none at all |
The single most valuable test is the old creatinine, which is why Amara's nephrologist began by pulling three years of results. Her hemoglobin of 11.2 g/dL, PTH of 88 pg/mL, and phosphate at the top of the range all say chronic: these are the endocrine consequences of functions 5 and 6 in Figure 26.1, and they take months to develop.
But the categories are not exclusive, and Amara illustrates the commonest real pattern: acute on chronic. She had slow diabetic and hypertensive damage for years (chronic), and then six weeks of heart failure, contrast, and diuresis on top of it (acute). The acute component may partly recover; the chronic component will not.
Chronic kidney disease: losing seven functions, not one
Return to Figure 26.1 and cross out the functions one at a time. That is what CKD feels like from the inside.
| Function lost | Consequence | Amara's evidence | Why it matters downstream |
|---|---|---|---|
| 5 · Erythropoietin | Normocytic anemia, usually appearing below GFR 60 | Hb 11.2 g/dL | Anemia forces a higher cardiac output to deliver the same oxygen — extra work for a failing heart. Loop closes again. |
| 6 · Calcitriol | Less intestinal Ca²⁺ absorption → hypocalcemia → secondary hyperparathyroidism; with retained phosphate and rising FGF23 | PTH 88 pg/mL, phosphate 4.4 mg/dL | CKD–mineral and bone disorder: bone resorption and fracture (Chapter 6 — Adwoa's territory) plus calcification of arteries and valves |
| 3 · Acid excretion | Metabolic acidosis, as ammoniagenesis capacity falls | HCO₃⁻ 21 mEq/L | Acid is buffered by bone (more calcium loss), drives muscle catabolism, and shifts K⁺ out of cells |
| 2 · K⁺ excretion | Hyperkalemia, especially once GFR < 20 or aldosterone is blocked | K⁺ 4.9 mEq/L | The acute killer — see the next sidebar |
| 4 · Blood pressure | Volume-dependent hypertension, RAAS-driven | 138/84 on treatment | Accelerates both cardiac and renal damage |
| 1 · Waste excretion | Uremia: nausea, pruritus, pericarditis, encephalopathy, platelet dysfunction | Not yet | The classic indications for starting dialysis |
Note the ordering. Amara has already lost measurable amounts of functions 2, 3, 4, 5, and 6, and none of function 1, which is the one everybody thinks of as kidney function. Waste excretion is the last thing to fail.
Clinical Connection · Hyperkalemia — Why Potassium Is the Acute Killer
Potassium excretion depends on three things: distal flow rate, distal sodium delivery, and aldosterone acting on principal cells to open ROMK. Chronic kidney disease attacks all three, and the drugs that protect the kidney attack the third directly.
The kidney adapts remarkably well for a long time. Surviving nephrons raise their fractional potassium excretion, and the colon takes on up to 30–40% of daily potassium removal. Serum potassium therefore stays normal until GFR falls below roughly 20 mL/min — unless something disables the adaptation: an ACE inhibitor, ARB, or MRA (less aldosterone), a beta-blocker (less cellular uptake), metabolic acidosis (potassium shifts out of cells in exchange for H⁺), tissue breakdown, or a potassium supplement.
Amara sits at 4.9 mEq/L with three of those pressures at once: an ACE inhibitor, a bicarbonate of 21, and a GFR of 46. The furosemide is what is keeping her safe — loop diuretics waste potassium briskly, and here that is a feature rather than a side effect. Her potassium is the ceiling on how much RAAS blockade she can be given, which is why it is checked one to two weeks after every dose change.
Why potassium kills. Resting membrane potential is set almost entirely by the potassium gradient across the membrane (Chapter 11). Raise extracellular potassium and the resting potential becomes less negative, moving it closer to threshold — which sounds like it should make cells more excitable, and briefly does — but sustained depolarization inactivates voltage-gated sodium channels, and inexcitable cardiac muscle cannot conduct. The ECG marches through it in order: peaked T waves → PR prolongation → loss of P waves → QRS widening → sine wave → asystole.
The treatment order follows the mechanism, and it is worth memorizing as a piece of reasoning rather than a list. First, intravenous calcium — it does not lower potassium at all; it raises the threshold potential back away from the resting potential and buys minutes. Second, shift potassium into cells with insulin plus glucose, or a nebulized beta-2 agonist, or correction of acidosis. Third, and only third, remove it from the body: a loop diuretic if urine still flows, an oral potassium binder, or dialysis. Stabilize, shift, remove.
Clinical Connection · Dialysis — Rebuilding a Nephron out of Plastic
Hemodialysis puts blood on one side of a semipermeable membrane and dialysate on the other, flowing in the opposite direction. Two physical processes do the work, and both were described earlier in this chapter under other names.
Diffusion moves solutes down their concentration gradients. Dialysate contains no urea, creatinine, or phosphate, so those move out of the blood; it contains bicarbonate at a higher concentration than uremic blood, so that moves in; potassium is set low, so potassium leaves. Countercurrent flow keeps a concentration difference along the entire length of the filter, exactly as it does in the vasa recta (§26.6) — the same physics, run for the opposite purpose.
Ultrafiltration removes water by imposing a hydrostatic pressure difference across the membrane. This is a manufactured version of glomerular filtration (§26.4), with a pump instead of an afferent arteriole.
Peritoneal dialysis uses the patient's own peritoneum — the serous membrane of Chapter 1 — as the semipermeable membrane, instilling dialysate into the peritoneal cavity and draining it after a dwell.
What dialysis does not do is the more important half. Four hours, three times a week, provides solute clearance equivalent to a GFR of only about 10–15 mL/min, and it provides it in intermittent bursts rather than continuously — which is why patients feel worst at the end of the long interdialytic gap. It does not make erythropoietin (so EPO is injected), does not activate vitamin D (so calcitriol analogues are prescribed), does not secrete renin appropriately, does not perform gluconeogenesis, and cannot respond minute-to-minute to a meal or a hot day. Dialysis replaces part of one of the kidney's seven functions.
Transplantation restores all seven, which is why it is the treatment of choice and why the living donor of §26.8 is such an instructive figure: one healthy kidney, hyperfiltering, is enough for two people.
Diuretics by class and segment
Every diuretic works by blocking a sodium-reabsorbing step somewhere along Figure 26.6. Where it blocks determines its potency, its electrolyte side effects, and its clinical use — all three are predictable from the anatomy.
SITES OF ACTION OF THE FOUR DIURETIC CLASSES
[1] [2] [3] [4]
┌────────┐ ┌─────────────────┐ ┌────────┐ ┌──────────┐
│ PCT │ │ THICK ASCENDING │ │ DCT │ │COLLECTING│
│ │ │ LIMB │ │ │ │ DUCT │
│ 65% Na │ │ 25% Na │ │ 5–8% Na│ │ ~3% Na │
└───┬────┘ └────────┬────────┘ └───┬────┘ └────┬─────┘
│ │ │ │
CARBONIC NKCC2 NCC ENaC / MINERALO-
ANHYDRASE (Na-K-2Cl) (Na-Cl) CORTICOID RECEPTOR
▲ ▲ ▲ ▲
│ │ │ │
ACETAZOLAMIDE ★ LOOP DIURETICS THIAZIDES AMILORIDE (ENaC)
furosemide HCTZ, TRIAMTERENE (ENaC)
bumetanide chlorthal- SPIRONOLACTONE (MR)
torsemide idone EPLERENONE (MR)
═══════════════════════════════════════════════════════════════════
CLASS MAX % of filtered Na+ excreted KEY CONSEQUENCES
───────────────────────────────────────────────────────────────────
Carbonic anh. ~5% HCO3- lost → metabolic ACIDOSIS.
(acetazolamide) Uses: glaucoma, altitude sickness.
───────────────────────────────────────────────────────────────────
LOOP 20–25% MOST POTENT (blocks the biggest active
(furosemide) ★ step AND destroys the medullary
gradient). ↓K+, ↓Mg2+, ↓Ca2+ (lumen-
positive voltage lost), metabolic
ALKALOSIS, ototoxicity at high dose.
Uses: heart failure, pulmonary edema,
hypercalcemia. ← AMARA'S DRUG
───────────────────────────────────────────────────────────────────
THIAZIDE 5–8% ↓K+, ↓Na+ (hyponatremia — the classic
(HCTZ, chlor- outpatient cause), ↑Ca2+ (opposite of
thalidone) loops), ↑urate, ↑glucose.
Uses: hypertension, calcium stones,
nephrogenic diabetes insipidus.
───────────────────────────────────────────────────────────────────
K+-SPARING 1–3% ↑K+ (hyperkalemia — the hazard).
ENaC blockers MRAs also reduce cardiac fibrosis and
+ MRAs cut mortality in heart failure.
Spironolactone: gynecomastia.
═══════════════════════════════════════════════════════════════════
NOT CLASSICAL DIURETICS BUT ACTING ON THE SAME TUBULE:
OSMOTIC (mannitol) — PCT + descending limb; non-reabsorbable solute
SGLT2 INHIBITORS — PCT; natriuresis + restores tubuloglomerular
feedback → afferent constriction → renoprotection
V2 ANTAGONISTS — collecting duct; excrete WATER only (aquaretic)
Figure 26.10 — The four diuretic classes, their target segments, and the consequences that follow from each site.
Described: A diagram of four tubule segments with the diuretic class acting at each. At the proximal convoluted tubule, which reabsorbs 65 percent of filtered sodium, carbonic anhydrase is the target and acetazolamide is the drug; maximum sodium excretion is about 5 percent and the characteristic consequence is loss of bicarbonate causing metabolic acidosis, with uses in glaucoma and altitude sickness. At the thick ascending limb, which reabsorbs 25 percent of sodium, the NKCC2 sodium-potassium-two-chloride cotransporter is the target and the loop diuretics furosemide, bumetanide, and torsemide are the drugs; these are the most potent class, excreting 20 to 25 percent of filtered sodium, because they block the largest active step and also destroy the medullary concentrating gradient, and their consequences are loss of potassium, magnesium, and calcium — the last because the lumen-positive voltage that drives paracellular calcium reabsorption is abolished — plus metabolic alkalosis and, at high dose, ototoxicity; their uses are heart failure, pulmonary edema, and hypercalcemia, and this is the class Amara takes. At the distal convoluted tubule, which reabsorbs 5 to 8 percent of sodium, the NCC sodium-chloride cotransporter is the target and the thiazides hydrochlorothiazide and chlorthalidone are the drugs; consequences are loss of potassium, hyponatremia, retention of calcium — the opposite of loop diuretics — and raised urate and glucose, with uses in hypertension, calcium stone prevention, and nephrogenic diabetes insipidus. At the collecting duct, which reabsorbs about 3 percent of sodium, the targets are the ENaC sodium channel, blocked by amiloride and triamterene, and the mineralocorticoid receptor, blocked by spironolactone and eplerenone; these excrete only 1 to 3 percent of filtered sodium and their hazard is hyperkalemia, while the mineralocorticoid antagonists additionally reduce cardiac fibrosis and lower mortality in heart failure. Three further agents acting on the same tubule are listed: osmotic diuretics such as mannitol acting in the proximal tubule and descending limb as non-reabsorbable solute; SGLT2 inhibitors acting in the proximal tubule to produce natriuresis and to restore tubuloglomerular feedback, constricting the afferent arteriole and protecting the kidney; and vasopressin V2 antagonists acting on the collecting duct to excrete water alone.
Three inferences the figure supports directly:
- Potency tracks the size of the step blocked. The PCT reabsorbs the most sodium, but blocking it barely works, because the downstream segments simply pick up the extra. The thick ascending limb is the sweet spot: a big step, with only small-capacity segments downstream. That is why loop diuretics are the potent class.
- Every diuretic that delivers more sodium to the collecting duct wastes potassium, because ENaC-driven sodium entry there makes the lumen negative and drives K⁺ secretion through ROMK. Loops and thiazides therefore both cause hypokalemia — and the combination of a loop diuretic with an ACE inhibitor, as in Amara, is a deliberate balancing of one drug's hypokalemia against the other's hyperkalemia.
- Loops and thiazides do opposite things to calcium, for the segment-specific reasons in §26.5 — which is why one is used to treat hypercalcemia and the other to prevent calcium stones.
Finally, the answer to the second half of Case File question 3. Amara's two drugs are not doing the same job. The loop diuretic treats her symptoms: it removes retained volume, lowers preload, relieves congestion — and, by lowering renal venous pressure, actually helps her GFR rather than harming it. It does not slow her kidney disease at all. The ACE inhibitor treats her trajectory: it lowers intraglomerular pressure, reduces albuminuria, and slows nephron loss over years, at the cost of a small immediate rise in creatinine. One drug is for this week; the other is for the next decade. Keeping both is not a compromise. It is two different prescriptions addressing two different arms of the same loop.
Chapter Summary
§26.1 The kidney performs seven functions — waste excretion, water and electrolyte balance, acid-base balance, blood pressure control through renin, erythropoietin secretion, calcitriol activation, and gluconeogenesis — of which only the first is what most people mean by "kidney function." The kidneys are retroperitoneal at T12–L3, the right lower than the left, wrapped in fibrous capsule, fat, and renal fascia. Internally, cortex surrounds a medulla of 8–18 pyramids separated by renal columns; each papilla drains to a minor calyx, then major calyx, pelvis, and ureter. Filtration happens only in the cortex; concentration only in the medulla. The ureter's three narrowings determine where stones lodge; its oblique bladder entry is the antireflux valve. The female urethra is 3–4 cm and the male 18–20 cm, which is why infection is a female problem and obstruction a male one.
§26.2 A kidney is about a million nephrons in parallel, and nephrogenesis stops at 36 weeks — you never make another. Cortical nephrons (85%) filter; juxtamedullary nephrons (15%), with long loops and vasa recta, build the medullary gradient. The renal corpuscle filters through three barriers: fenestrated endothelium (excludes cells), the glomerular basement membrane (excludes proteins by size and by negative charge), and podocyte filtration slits (the final size filter). Albuminuria is barrier failure, and Amara's ACR of 180 mg/g is a biopsy result obtained from a urine cup. The juxtaglomerular complex — macula densa, granular cells, extraglomerular mesangial cells — is where a nephron regulates itself and where renin is made.
§26.3 Uniquely, renal blood passes through two capillary beds in series. The glomerular bed runs at ~55 mm Hg and filters; the peritubular bed runs at ~13–15 mm Hg with high oncotic pressure and reabsorbs. Because there is a resistance vessel on both sides, glomerular pressure and renal blood flow can be set independently. Afferent constriction lowers both flow and GFR; efferent constriction lowers flow but raises GFR — the dissociation that angiotensin II exploits and that ACE inhibitors reverse.
§26.4 NFP = 55 − (15 + 30) = 10 mm Hg, and that tiny pressure across an enormous, leaky membrane yields GFR ≈ 125 mL/min = 180 L/day, of which more than 99% is reabsorbed. GFR is defended by autoregulation (myogenic stretch response plus tubuloglomerular feedback at the macula densa) between MAP 80–180 mm Hg, overridden by sympathetic activation in stress, and modulated by the RAAS, whose three renin stimuli are low arteriolar stretch, low macula densa NaCl, and β₁ stimulation.
§26.5 The basolateral Na⁺/K⁺ ATPase is the engine: every apical transporter in the nephron spends the sodium gradient it creates. The PCT obligatorily and isosmotically reabsorbs 65% of salt and water and 100% of glucose and amino acids; the thick ascending limb actively reabsorbs 25% of sodium while excluding water, making the fluid hypo-osmotic; the DCT and collecting duct are the regulated segments where aldosterone, ADH, and acid-base status decide the final urine. Transport maximum and renal threshold explain glycosuria — and because filtered load equals GFR × plasma concentration, glycosuria disappears as GFR falls.
§26.6 The countercurrent multiplier turns a 200 mOsm single effect in the thick ascending limb into a 300 → 1200 mOsm axial gradient, by counterflow through a hairpin. Urea recycling supplies about half the papillary osmolality at no energy cost. The vasa recta preserve the gradient by passive countercurrent exchange with slow flow. ADH then decides whether the gradient is used, by inserting aquaporin-2 into the apical membrane of collecting duct principal cells within minutes.
§26.7 Water balance defends osmolality and is run by osmoreceptors, ADH, and thirst. Sodium balance defends volume and is run by baroreceptors, the RAAS, and the natriuretic peptides. Keeping them separate is why hyponatremia is a water problem, not a salt problem, and why a patient can be simultaneously sodium-overloaded and hyponatremic.
§26.8 Clearance is the volume of plasma cleared per minute; inulin measures GFR exactly, creatinine overestimates it by 10–20% because of tubular secretion, and PAH measures renal plasma flow. Plasma creatinine is inversely proportional to GFR, so half of kidney function can be lost inside the reference interval — compounded by renal reserve and compensatory hyperfiltration, which defend GFR while destroying the nephrons doing the defending. Albuminuria is the earlier and better marker. Urinalysis and casts localize disease within the nephron.
§26.9 Storage is sympathetic and somatic; voiding is parasympathetic, gated by the pontine micturition centre under cortical control, and completed by a positive feedback loop that ends when the bladder empties. Incontinence is classified by which part of that system failed.
§26.10 In the cardiorenal loop, falling cardiac output reduces renal perfusion, activating the RAAS, which retains salt and water and raises afterload — increasing preload and workload on a heart that already cannot cope, so cardiac output falls further. Every arrow is an adaptive mechanism misapplied. AKI is prerenal, intrinsic, or postrenal, distinguished by whether the tubules can still conserve sodium. CKD is staged by GFR and albuminuria and produces anemia, mineral-bone disorder, acidosis, and hyperkalemia by losing functions 5, 6, 3, and 2 — long before uremia. Diuretics are classified by segment, and every property of each class follows from where it acts.
The Three Threads in Chapter 26
Structure → Function. The medulla is striped because countercurrent exchange requires parallel counterflow. The PCT has a brush border and the DCT does not, because one is a bulk absorber and the other a regulator. The glomerulus has an arteriole at both ends because its pressure must be independently controllable. The podocyte's foot processes are the filter, which is why a disease that only changes their shape can cost you 10 grams of protein a day.
Homeostasis. The kidney is the body's final common regulator: it sets the volume, the osmolality, the electrolyte concentrations, the pH, and the pressure of the fluid every other cell lives in. Every mechanism in this chapter — autoregulation, tubuloglomerular feedback, the RAAS, ADH, the natriuretic peptides — is a negative feedback loop with a receptor, a control centre, and an effector. And Chapter 1's warning holds: separating water regulation from sodium regulation is separating two loops that defend two different variables through the same organ.
Integration. This is the chapter where the cardiorenal loop closes. A heart problem became a kidney problem through baroreceptors and angiotensin II; the kidney problem became a bone problem through calcitriol, a blood problem through erythropoietin, and an acid-base problem through ammoniagenesis; and the fluid the kidney retained went back to make the heart worse. Amara does not have five diseases. She has one loop, sampled in five places.
Case File 26 · Resolution
Question 1 — How can creatinine barely move from 0.9 to 1.4 while the kidney loses about half its function?
Because plasma creatinine is inversely proportional to GFR, not linearly related to it (§26.8). At steady state, creatinine production equals creatinine excretion, so P_cr = production ÷ GFR — a rectangular hyperbola. On the flat part of that curve, at high GFR, halving the filtration rate only doubles a very small number. On the steep part, at low GFR, a tiny further loss doubles a large number.
Run Amara's own figures. Her creatinine of 0.9 mg/dL at 42 corresponds to an eGFR of about 82 mL/min/1.73 m². Her 1.4 mg/dL at 45 corresponds to 46. Measured filtration has fallen 44%, and the creatinine moved 0.5 mg/dL — three-fifths of it while still inside the laboratory's reference interval of 0.5–1.1. Two of the four values her nephrologist pulled were reported as normal by a machine that was, arithmetically, entirely correct.
Three further effects deepen the blindness.
Renal reserve. You filter far more than you need. The proof is the living kidney donor, whose GFR drops 50% overnight and recovers to 70–75% of baseline within weeks — with a normal creatinine. Half the renal mass can be removed without moving the test.
Compensatory hyperfiltration. When nephrons are lost, survivors raise their single-nephron GFR, so total GFR — and creatinine — are defended. This means the true nephron loss is greater than the 44% fall in her measured GFR suggests. It also means the compensation is complicit: raised single-nephron pressure is exactly what injures podocytes and drives the next round of loss.
Early diabetic hyperfiltration. Before her decline began, Amara's GFR was probably above normal — 130 or more — driven by SGLT2 upregulation reducing macula densa sodium delivery and dilating the afferent arteriole. During that phase her creatinine may have been not merely normal but low, at a time when her glomeruli were already being damaged. The test was not just insensitive; it was pointing the wrong way.
What should have been measured instead is the urine albumin-to-creatinine ratio, which reports on the filtration barrier rather than the filtration rate, and which rises years earlier. Hers is 180 mg/g. Nobody checked it until today.
So the honest answer to Amara's question is that the creatinine behaved exactly as an inverse function must. What failed was the belief that "within the reference interval" means "within a normal state."
Question 2 — Why does a failing heart make the kidneys retain salt and water, and why does that retention make the heart worse?
Because the body has no sensor for cardiac output. It has sensors for arterial pressure — carotid and aortic baroreceptors, and the stretch-sensitive granular cells of the afferent arteriole — and those sensors cannot distinguish "there is not enough blood" from "there is plenty of blood but the pump cannot move it."
The chain (Figure 26.9), in order:
- Amara's stiff left ventricle limits stroke volume, so cardiac output falls.
- Arterial pressure and renal perfusion fall. Baroreceptors unload; the sympathetic nervous system activates; renal perfusion pressure and macula densa NaCl fall.
- All three renin stimuli fire at once → renin → angiotensin I → angiotensin II → aldosterone.
- Angiotensin II does four things simultaneously: constricts efferent arterioles (propping up GFR, and incidentally raising filtration fraction so that peritubular oncotic pressure rises and the proximal tubule reabsorbs more sodium by pure physics — §26.3); directly stimulates PCT sodium reabsorption; triggers aldosterone, which opens ENaC in the collecting duct; and constricts systemic arterioles. Baroreceptor-driven ADH release retains water on top of it.
- Salt and water are retained. Blood volume and preload rise. In a stiff ventricle, a small volume increase produces a large pressure increase, so pulmonary venous pressure climbs and she becomes short of breath. Her ankles swell.
- Meanwhile systemic vasoconstriction has raised afterload, so the same ventricle must generate more pressure to eject the same volume.
- Higher preload plus higher afterload means higher wall stress and higher myocardial oxygen demand, in a heart with narrowed coronary arteries. Stroke volume falls further. Cardiac output falls further. Return to step 1.
That is a positive feedback loop, and it is made entirely of negative feedback mechanisms operating on the wrong signal. There are two additional arms worth naming. The venous arm: raised central venous pressure is transmitted back to the renal veins, reducing the arteriovenous pressure gradient across the kidney and raising renal interstitial pressure, which lowers GFR independently of forward flow — venous congestion damages the kidney as much as low output does. And the chronic arm: sustained high glomerular pressure injures podocytes, producing the albuminuria and progressive nephron loss that leave her less able to regulate volume next year than this year.
The body does push back. Stretched atria and ventricles release ANP and BNP, which excrete sodium, dilate the afferent arteriole, and inhibit renin, aldosterone, and ADH. Her BNP is elevated — which is why it is a useful diagnostic marker. But in chronic heart failure the RAAS overwhelms the natriuretic peptides, so BNP ends up reporting the loop rather than braking it.
This also explains the therapeutic logic that otherwise looks perverse: the drugs that improve survival in heart failure — ACE inhibitors, beta-blockers, mineralocorticoid antagonists — all block a compensation. They work by interrupting the loop, not by strengthening the pump.
Question 3 — Why keep a drug that raises creatinine?
Because the creatinine rise is the evidence that the drug is working, and the mechanism that raises it is the same mechanism that protects the kidney.
Angiotensin II preferentially constricts the efferent arteriole. In Amara, chronically high angiotensin II was holding her glomerular hydrostatic pressure well above normal — perhaps 60–65 rather than 55 mm Hg — and thereby propping up a GFR that her renal perfusion could not otherwise support. Her creatinine of 1.1 on admission was, in part, a number rescued by a squeeze.
Lisinopril blocks ACE. Angiotensin II falls. The efferent arteriole relaxes. Glomerular hydrostatic pressure drops, NFP falls, and GFR falls with it. Creatinine rises from 1.1 to 1.4 — a 27% rise, which sits inside the accepted threshold of about 30%, and which stabilizes rather than climbing.
Why is losing filtration good? Because the pressure that was buying it was destroying the filter. Podocytes are terminally differentiated and cannot divide. Sustained intraglomerular hypertension stretches them until they efface, detach, and are lost in the urine; the denuded basement membrane adheres to Bowman's capsule; angiotensin II and mechanical stretch drive mesangial cells to lay down matrix; and the glomerulus sclerosis. The albumin escaping into the tubule is itself inflammatory and drives interstitial fibrosis. High glomerular pressure buys filtration this year and pays for it with nephrons for the rest of her life.
So the trade is explicit: a small, immediate, reversible fall in GFR in exchange for a slower rate of nephron loss over decades, plus a fall in albuminuria, which is itself the best available predictor of her renal and cardiovascular future. The monitoring rules follow directly — recheck creatinine and potassium in one to two weeks; accept a rise up to ~30% that plateaus; investigate a larger or progressive rise (classically bilateral renal artery stenosis, where the efferent squeeze was the only thing maintaining filtration); and watch potassium, because less aldosterone means less K⁺ secretion and she is already at 4.9 mEq/L.
And the loop diuretic is kept because it is doing a different job. Furosemide blocks NKCC2 in the thick ascending limb, excretes up to a quarter of the filtered sodium load, and removes the volume the cardiorenal loop retained. That relieves her dyspnea and ankle edema; it lowers her central venous pressure, which actually improves renal perfusion by restoring the arteriovenous gradient across the kidney; and it wastes potassium, which offsets the ACE inhibitor's tendency to retain it. What it does not do is slow her kidney disease at all.
One drug treats this week. The other treats the next decade. Keeping both is not indecision — it is two prescriptions aimed at two different arms of one loop.
Systems Integration Case File · Entry 26
Entry 26 — The loop closes
New findings for your file: serum creatinine 1.4 mg/dL, eGFR 46 mL/min/1.73 m² (stage G3a); urine albumin-to-creatinine ratio 180 mg/g (A2); potassium 4.9 mEq/L; bicarbonate 21 mEq/L; hemoglobin 11.2 g/dL; phosphate 4.4 mg/dL; intact PTH 88 pg/mL; blood pressure 138/84 mm Hg on lisinopril and furosemide.
Your entry:
1 · ADD. In two or three sentences, state what the urinary system contributes to Amara's picture. Name at least three of the kidney's seven functions that are measurably impaired, and give the number that proves each.
2 · CONNECT. Link the kidney to at least two systems already in your file, stating the direction of causation each time. At least one of your links must be a loop — a chain that returns to where it started.
3 · PREDICT. Chapter 31 covers fluid, electrolyte, and acid-base balance. Predict one specific electrolyte or acid-base abnormality Amara will develop, name the drug or mechanism that will cause it, and say which direction it will go.
Model responses — read only after writing your own
1 · ADD. Amara has stage 3a chronic kidney disease with moderately increased albuminuria: her eGFR of 46 mL/min/1.73 m² represents a loss of roughly 44% of measured filtration, and her ACR of 180 mg/g proves the loss is glomerular rather than purely hemodynamic. At least four of the kidney's seven functions are already impaired — erythropoietin (hemoglobin 11.2 g/dL), calcitriol activation (PTH 88 pg/mL with phosphate at 4.4, the signature of secondary hyperparathyroidism), acid excretion (bicarbonate 21 mEq/L), and blood pressure regulation (138/84 despite two antihypertensive agents). Waste excretion, the function everyone thinks of, is the one still working best.
2 · CONNECT. Cardiovascular → urinary: her failing left ventricle lowers cardiac output and renal perfusion pressure, which unloads baroreceptors and lowers macula densa sodium delivery, which releases renin; angiotensin II then constricts the efferent arteriole and drives proximal sodium reabsorption. Urinary → cardiovascular (closing the loop): the resulting sodium and water retention raises preload while angiotensin II raises afterload, and both increase the workload of a stiff ventricle, lowering cardiac output further — a positive feedback loop assembled entirely from negative feedback parts. Endocrine → urinary: twelve years of hyperglycemia (fasting glucose 212, A1c 7.4%) upregulated SGLT2, reduced macula densa sodium delivery, dilated the afferent arteriole, and produced the glomerular hypertension that stripped charge from her basement membrane and stressed her podocytes. Urinary → skeletal: loss of 1α-hydroxylase activity lowers calcitriol, which lowers intestinal calcium absorption, which raises PTH, which resorbs bone — the same pathway that produced Adwoa's osteoporosis, arriving in Amara three decades early by a different route. Urinary → hematologic: loss of peritubular erythropoietin production lowers red cell production, and the resulting anemia forces a higher cardiac output for the same oxygen delivery, which is a third route back to the heart.
3 · PREDICT. Hypokalemia with a metabolic alkalosis, caused by the furosemide. Blocking NKCC2 delivers a large sodium load to the collecting duct, where ENaC-driven sodium entry makes the lumen negative and drives potassium secretion through ROMK; volume depletion raises aldosterone, which amplifies both potassium and hydrogen ion secretion; and the contraction of extracellular volume around a fixed bicarbonate mass concentrates it further. Direction: potassium down, bicarbonate up. A defensible alternative prediction is hyperkalemia instead, if the ACE inhibitor dose is increased, an MRA is added, or her GFR falls further — and predicting both, with the conditions under which each would win, is the strongest answer of all.
Review
Level 1 · Recall
22.1 The three layers of the glomerular filtration membrane, from blood to filtrate, are:
a) podocytes → basement membrane → fenestrated endothelium b) fenestrated endothelium → basement membrane → podocyte filtration slits c) basement membrane → fenestrated endothelium → mesangial cells d) parietal layer → visceral layer → basement membrane
Answer
b. Blood meets the fenestrated endothelium first (excluding cells), then the glomerular basement membrane (excluding proteins by size and by negative charge), then the podocyte filtration slits (the final size filter). Option a reverses the order. c puts the basement membrane before the endothelium and adds mesangial cells, which support the tuft but are not part of the barrier. d describes the two layers of Bowman's capsule, not the filtration membrane.
22.2 Net filtration pressure at the glomerulus is approximately:
a) 55 mm Hg b) 30 mm Hg c) 15 mm Hg d) 10 mm Hg
Answer
d — 10 mm Hg. NFP = glomerular hydrostatic (55) − [capsular hydrostatic (15) + blood colloid osmotic (30)] = 10. The distractors are the individual terms: 55 is the glomerular hydrostatic pressure alone, 30 the oncotic pressure, and 15 the capsular pressure.
22.3 Constricting the efferent arteriole will:
a) decrease renal blood flow and decrease GFR b) increase renal blood flow and increase GFR c) decrease renal blood flow and increase GFR d) leave both unchanged
Answer
c. The efferent arteriole is downstream of the glomerulus, so constricting it obstructs outflow: total flow through the kidney falls, but pressure builds up inside the glomerulus, so filtration rises. This dissociation is the basis of angiotensin II's renal action and of the creatinine rise seen with ACE inhibitors. Option a describes afferent constriction.
22.4 Approximately what fraction of filtered sodium and water is reabsorbed in the proximal convoluted tubule?
a) 25% b) 45% c) 65% d) 90%
Answer
c — 65%. The thick ascending limb takes another 25%, the DCT 5–8%, and the collecting duct about 3%. Note that only the last two are hormonally regulated: the PCT's reabsorption is obligatory and isosmotic, which is why blocking it (with acetazolamide) is a weak diuretic strategy — downstream segments simply absorb the extra.
22.5 The osmolality of tubular fluid leaving the thick ascending limb of the loop of Henle is:
a) about 50 mOsm/kg b) about 100 mOsm/kg c) about 300 mOsm/kg d) about 1200 mOsm/kg
Answer
b — about 100 mOsm/kg, hypo-osmotic. The thick ascending limb pumps NaCl out while remaining impermeable to water, so it dilutes the fluid; this is why it is called the diluting segment. 300 mOsm/kg (c) is the fluid leaving the isosmotic PCT; 1200 (d) is the fluid at the hairpin of a long loop and the maximum concentration of final urine; 50 (a) is the minimum osmolality of final urine after further dilution in the DCT and collecting duct with no ADH.
22.6 ADH increases water reabsorption by:
a) opening sodium channels in the collecting duct b) inserting aquaporin-2 channels into the apical membrane of principal cells c) increasing NKCC2 activity in the thick ascending limb d) dilating the afferent arteriole
Answer
b. ADH acts through basolateral V2 receptors, Gs, cAMP, and protein kinase A to phosphorylate aquaporin-2 and cause AQP2-bearing vesicles to fuse with the apical membrane — a response taking minutes because the channels already exist and are merely relocated. Option a describes aldosterone's action on ENaC; c is what loop diuretics block; d is not an ADH action.
22.7 A substance whose renal clearance exceeds the clearance of inulin must be:
a) reabsorbed b) secreted c) neither reabsorbed nor secreted d) not filtered
Answer
b — secreted. Inulin clearance equals GFR. More of a substance appearing in the urine than filtration alone could account for means the tubule is adding it. PAH is the extreme example, with a clearance ratio near 5, which is why it measures renal plasma flow rather than GFR.
22.8 Loop diuretics cause hypocalcemia because they:
a) block calcium channels in the distal convoluted tubule b) abolish the lumen-positive potential in the thick ascending limb c) inhibit parathyroid hormone secretion d) prevent calcitriol activation in the proximal tubule
Answer
b. In the thick ascending limb, potassium recycling through ROMK creates a lumen-positive voltage of about +8 mV, and that voltage drives paracellular reabsorption of calcium and magnesium. Blocking NKCC2 removes the potassium recycling, removes the voltage, and stops the calcium reabsorption. Note that thiazides do the opposite — by blocking NCC in the DCT they lower intracellular sodium, speed the basolateral Na⁺/Ca²⁺ exchanger, and increase calcium reabsorption. Same ion, opposite effects, purely because of the segment.
Level 2 · Comprehension
22.9 Explain why the kidney needs two capillary beds in series, and what would go wrong if the glomerulus drained directly into a vein.
Model answer
The two beds perform opposite functions and require opposite pressures. Filtration needs a high hydrostatic pressure (~55 mm Hg); reabsorption needs a low hydrostatic pressure (~13–15 mm Hg) combined with a high colloid osmotic pressure. Putting an efferent arteriole between them lets the kidney manufacture both conditions from the same blood, in sequence: the arteriole drops the pressure by about 40 mm Hg, and the act of filtering has already concentrated the plasma proteins left behind, raising oncotic pressure from about 28 to 35 mm Hg. Low pressure plus high oncotic pressure is precisely the recipe for reabsorption.
If the glomerulus drained straight into a vein, three things would fail. Glomerular pressure would be set by venous pressure and could no longer be regulated independently of renal blood flow, so GFR would swing with every change in systemic pressure. There would be no low-pressure, high-oncotic capillary bed adjacent to the tubule, so the 178.5 litres reabsorbed each day would have nowhere to go. And the kidney would lose its most important control lever — the efferent arteriole — which is what allows angiotensin II to defend GFR when perfusion falls, and what ACE inhibitors act on to protect the glomerulus.
22.10 Build the countercurrent multiplier from scratch in your own words, explaining specifically why the mechanism requires (i) an active transport step, (ii) differential water permeability, and (iii) flow in opposite directions.
Model answer
(i) The active step. NKCC2 in the thick ascending limb pumps NaCl out of the tubule into the interstitium, using energy borrowed from the basolateral Na⁺/K⁺ ATPase. Working alone at any single horizontal level it can create a difference of about 200 mOsm/kg between lumen and interstitium — the single effect. Without an energy-consuming step there is no gradient at all; osmotic gradients do not build themselves.
(ii) Differential water permeability. The ascending limb must be water-impermeable, otherwise water would follow the salt out and the tubular fluid would stay isosmotic no matter how hard the pump worked — no separation, no gradient. Conversely the descending limb must be water-permeable (aquaporin-1) and salt-impermeable, so that it equilibrates with the interstitium by losing water and its contents become progressively more concentrated as it descends.
(iii) Counterflow. With flow, fresh isosmotic fluid entering from the PCT pushes the column along, so fluid that was concentrated in the descending limb rounds the hairpin and is pumped on again by the ascending limb. Each cycle applies the 200 mOsm single effect to fluid that is already more concentrated than the last, so the transverse 200 mOsm difference is multiplied into an axial gradient of about 900 mOsm along the length of the medulla — 300 at the corticomedullary junction to 1200 at the papilla. Loop length therefore sets maximum concentrating power, which is why the long-looped juxtamedullary nephrons build the gradient and the short-looped cortical nephrons merely use it.
Add two supports: urea recycling supplies roughly half the papillary osmoles at no energy cost, and the vasa recta preserve the gradient by passive countercurrent exchange with deliberately slow flow.
22.11 A patient's serum sodium is 128 mEq/L. Their ankles are swollen, their jugular venous pressure is raised, and they have crackles at both lung bases. Explain how they can be simultaneously overloaded with sodium and hyponatremic, and say what you would and would not do about it.
Model answer
Because sodium balance and water balance defend different variables (§26.7). Total body sodium determines extracellular volume, and this patient's edema, raised JVP, and pulmonary crackles prove that total body sodium is high — several litres of extra salt water are being carried. Serum sodium concentration is a ratio of sodium to water, and it is set by ADH.
In heart failure, arterial baroreceptors sense low effective arterial pressure and drive ADH release non-osmotically — the volume pathway overriding the osmolality pathway, exactly as described in §26.6. Water is therefore retained even harder than sodium is, and the ratio falls. Both statements are true at once: too much sodium in the body, too little sodium per litre of plasma.
What you would do: treat the underlying cardiac problem and the volume overload (loop diuretic, which removes salt water and reduces congestion), restrict free water, and consider a V2 antagonist if the hyponatremia is severe — it excretes water without excreting sodium. What you would not do is give sodium: adding salt to a patient already carrying excess sodium worsens the congestion without correcting the underlying problem, which is a water excess. Correction must also be gradual, because rapid correction of chronic hyponatremia risks osmotic demyelination (Chapter 31).
Level 3 · Clinical Application
22.12 A 62-year-old man is brought in after being found on the floor of his flat, where he had lain for about 18 hours after a fall. His creatine kinase is 42,000 U/L, potassium 6.1 mEq/L, creatinine 3.2 mg/dL, and calcium 7.1 mg/dL. Urine is dark; dipstick is strongly positive for blood but microscopy shows no red cells. Explain every finding and state the first two treatment priorities in order.
Model answer
This is rhabdomyolysis with myoglobinuric acute kidney injury. Prolonged pressure on muscle caused ischemic necrosis, releasing the intracellular contents of skeletal muscle into plasma.
- CK 42,000 is the marker of muscle breakdown itself.
- Potassium 6.1 because potassium is overwhelmingly intracellular and muscle is the largest reservoir of it; necrosis releases it directly, and the falling GFR removes the main route of disposal.
- Calcium 7.1 (low) because damaged muscle binds calcium avidly and because hyperphosphatemia from the same release precipitates calcium. (Expect rebound hypercalcemia during recovery as the deposits mobilize.)
- Creatinine 3.2 from acute kidney injury, and disproportionately high for the GFR because damaged muscle also releases creatine, which converts to creatinine.
- Dark urine, dipstick positive for blood, microscopy negative for red cells is the classic dissociation: the dipstick detects heme, and here the heme is myoglobin, a 17.8 kDa monomer small enough to be freely filtered (unlike 64 kDa hemoglobin, which is largely bound by haptoglobin).
Myoglobin injures the kidney three ways (§26.7): renal vasoconstriction from the hypovolemia caused by litres of fluid sequestering in damaged muscle; direct tubular toxicity from iron-catalysed free radicals; and intratubular cast formation with Tamm–Horsfall protein, worst in acidic, concentrated urine.
Priorities in order: (1) treat the hyperkalemia, because it can stop the heart in minutes — intravenous calcium first to stabilize the myocardium (it raises threshold potential and does not lower potassium), then insulin with glucose or a beta-2 agonist to shift potassium into cells, then removal. (2) Aggressive intravenous fluid resuscitation to restore renal perfusion, dilute the pigment, and keep urine flowing so that casts cannot form. Everything else — monitoring for compartment syndrome, watching for the delayed hypercalcemia — follows.
22.13 A 71-year-old woman with heart failure, on furosemide and lisinopril, develops knee pain and takes ibuprofen for five days. She presents with creatinine risen from 1.3 to 3.0 mg/dL, urine sodium 12 mEq/L, FE_Na 0.4%, urine osmolality 620 mOsm/kg, and a bland urinary sediment. Localize the injury, explain the mechanism at both arterioles, and predict what will happen when the ibuprofen is stopped.
Model answer
The urine indices localize this precisely to prerenal acute kidney injury: urine sodium under 20, FE_Na under 1%, urine osmolality over 500, and a bland sediment all say the tubules are intact and working hard to conserve sodium and water. A kidney with necrotic tubules could not produce that urine — it would be isosthenuric at about 300 mOsm/kg with a FE_Na above 2% and muddy-brown granular casts.
The mechanism is the "triple whammy", and it acts on both arterioles at once.
- Afferent arteriole: in a patient with reduced renal perfusion, afferent tone is maintained by locally synthesized vasodilator prostaglandins. Ibuprofen inhibits cyclooxygenase and removes them, so the afferent arteriole constricts and inflow falls.
- Efferent arteriole: lisinopril has removed angiotensin II, so the efferent arteriole cannot constrict to hold glomerular pressure up. Outflow stays wide open.
- Volume: furosemide has reduced circulating volume, so renal perfusion pressure was already marginal and the kidney was already dependent on both of the above.
Inflow restricted and outflow unopposed means glomerular hydrostatic pressure collapses; NFP, which was only 10 mm Hg to begin with, falls toward zero; and GFR falls sharply.
Prediction: stopping the ibuprofen restores prostaglandin-mediated afferent dilation within a day or two, and with careful volume repletion — and usually a temporary reduction or hold of the diuretic — the creatinine should return toward 1.3 over several days. It is functional, not structural. The important caveat is that sustained prerenal injury becomes acute tubular necrosis, because the outer medullary thick ascending limb has the highest ATP demand and the most marginal oxygen supply in the kidney; if she had presented a week later with muddy-brown casts and an FE_Na of 3%, recovery would take weeks rather than days.
22.14 A 24-year-old with type 1 diabetes has a plasma glucose of 480 mg/dL. Calculate her filtered glucose load at a GFR of 125 mL/min, state whether the transport maximum is exceeded, and explain both her polyuria and her thirst mechanistically.
Model answer
Filtered load = GFR × plasma concentration = 125 mL/min × 4.80 mg/mL = 600 mg/min.
The glucose transport maximum is about 375 mg/min, so the load exceeds Tm by roughly 225 mg/min. Every transporter is saturated, and about 225 mg of glucose per minute — around 324 g per day — passes on down the tubule. (The renal threshold of ~180 mg/dL was crossed long before Tm was reached, because of splay: nephrons are heterogeneous and the ones with the lowest Tm saturate first.)
Polyuria follows because glucose that is not reabsorbed remains in the tubular fluid as an osmotically active solute. It holds water in the lumen against the osmotic pull of the interstitium along the whole length of the tubule and, crucially, along the medullary collecting duct — so even maximal ADH cannot extract the water. This is an osmotic diuresis, and it is exactly the same mechanism by which mannitol works as a drug. Sodium is dragged along too, so the diuresis costs salt as well as water.
Thirst follows from what the diuresis does to plasma. Losing hypotonic fluid raises plasma osmolality, which is detected by hypothalamic osmoreceptors sensitive to ~1% change; they trigger both ADH release and thirst. The hyperglycemia itself contributes directly, since glucose is an effective osmole in the extracellular space. And as volume falls, baroreceptor input adds a second, non-osmotic drive to both ADH and thirst.
One footnote that connects to the chapter's main argument: if this patient later develops nephropathy and her GFR falls to 60, the same plasma glucose of 480 would produce a filtered load of only 288 mg/min — below Tm — and her glycosuria would diminish even though her diabetes had not improved at all. Filtered load, not blood concentration, is what the tubule sees.
Level 4 · Integration and Synthesis
22.15 Amara's nephrologist proposes adding an SGLT2 inhibitor. Explain the mechanism by which it protects the kidney, contrast that mechanism with the ACE inhibitor's, predict what will happen to her creatinine in the first four weeks and why, and identify one risk of using both drugs together.
Model answer
The mechanism runs through tubuloglomerular feedback. In diabetes, chronic hyperglycemia upregulates SGLT2 in the proximal tubule, so more sodium is reabsorbed proximally alongside glucose. Less sodium chloride therefore reaches the macula densa, which reads that as "this nephron's GFR is too low" and responds by dilating the afferent arteriole and stimulating renin. The result is glomerular hypertension and hyperfiltration — the first stage of diabetic nephropathy.
An SGLT2 inhibitor blocks proximal glucose-sodium cotransport, so more sodium chloride reaches the macula densa, so tubuloglomerular feedback constricts the afferent arteriole and lowers intraglomerular pressure. It also produces a modest natriuresis and osmotic diuresis, which lowers volume and blood pressure.
The contrast with the ACE inhibitor is the elegant part: both drugs lower glomerular pressure, but from opposite ends of the capillary. The ACE inhibitor dilates the efferent arteriole (reducing outflow resistance); the SGLT2 inhibitor constricts the afferent arteriole (reducing inflow). They are complementary rather than redundant, which is why the combination reduces progression more than either alone.
Prediction: her creatinine will rise again — typically another 0.1–0.3 mg/dL, with eGFR dipping perhaps 3–5 mL/min — over the first two to four weeks, and then stabilize, after which her rate of decline will be slower than it would otherwise have been. This "initial eGFR dip" has exactly the same meaning as the dip after starting lisinopril: it is the hemodynamic signature of the protective mechanism working, not evidence of harm.
Risks of the combination: volume depletion is the main one — an SGLT2 inhibitor's osmotic diuresis on top of furosemide, in a patient whose glomerular pressure is already unsupported by angiotensin II, can precipitate prerenal AKI, especially during an intercurrent illness (the reason for "sick day rules"). Genital mycotic infection is common because of the glycosuria, and euglycemic diabetic ketoacidosis is rare but serious. Note the one thing that is not a major risk: unlike an MRA, an SGLT2 inhibitor does not worsen hyperkalemia — it slightly reduces it — which matters for a patient sitting at 4.9 mEq/L.
22.16 Argue for or against the following claim, using at least four specific mechanisms from this chapter: "Chronic kidney disease is best understood not as a disease of the kidney but as a disease of every other organ."
Model answer
A strong answer argues substantially for the claim, then qualifies it.
Evidence for: CKD's clinical manifestations are almost entirely extrarenal, because six of the kidney's seven functions are services rendered to other organs.
- Hematologic. Loss of peritubular erythropoietin production causes a normocytic anemia appearing around GFR 60, which forces a higher cardiac output for the same oxygen delivery and accelerates left ventricular hypertrophy. Amara's hemoglobin is 11.2 g/dL.
- Skeletal and vascular. Loss of 1α-hydroxylase lowers calcitriol, reducing intestinal calcium absorption; retained phosphate raises FGF23, which suppresses calcitriol further; the result is secondary hyperparathyroidism, bone resorption, and — the lethal part — calcification of arteries and heart valves. Amara's PTH is already 88 pg/mL.
- Acid-base and muscle. Reduced ammoniagenesis lowers net acid excretion, producing a metabolic acidosis that is buffered by bone (more calcium loss) and drives muscle protein catabolism. Her bicarbonate is 21 mEq/L.
- Cardiovascular. Impaired sodium excretion plus inappropriate renin secretion produces volume-dependent hypertension, which damages the heart, the retina, the brain, and the remaining kidney. Most patients with CKD die of cardiovascular disease rather than reaching dialysis.
- Neurologic and hematologic, late. Retained uremic toxins cause encephalopathy, pruritus, pericarditis, and platelet dysfunction — the classic dialysis indications, and the last things to appear.
The qualification: the claim overstates in one respect. The renal lesion is real and primary — podocyte loss, glomerulosclerosis, interstitial fibrosis — and it is the thing that progresses. The correct formulation is that CKD is a disease of the kidney whose symptoms are borrowed from everywhere else, because the kidney's outputs are inputs to other systems. The reason this matters practically is that the treatments that change outcomes are aimed at the renal lesion (RAAS blockade, SGLT2 inhibition, blood pressure and glucose control) while the treatments that change symptoms are aimed at the extrarenal consequences (EPO, phosphate binders, vitamin D analogues, bicarbonate). Confusing the two is the commonest error in managing this disease.
22.17 Design a kidney for an animal living in an environment with unlimited fresh water and no salt. Specify what you would change about loop length, the medullary gradient, ADH, aldosterone, and the collecting duct, and justify each change. Then explain what your animal would die of if it were suddenly moved to a desert.
Model answer
The design. With unlimited water and no dietary salt, the homeostatic problem reverses: the animal must excrete enormous volumes of water while conserving every sodium ion.
- Loop length: short, or absent. The loop of Henle exists to build a medullary gradient for concentrating urine. An animal that never needs to concentrate has no use for it, and its long loops would be an expensive ATP liability. (Freshwater fish are the real-world case, and they indeed lack loops of Henle.)
- Medullary gradient: shallow or none. With no concentrating requirement, the medulla can be isosmotic with plasma. This also removes the need for slow-flowing vasa recta.
- ADH: minimal or absent. With water always in excess, the useful setting is permanent water-excreting mode. If retained at all, it would be for its V1 vasoconstrictor role rather than its V2 water role.
- Aldosterone: greatly amplified, and constitutively active. Salt is the scarce resource, so the animal needs maximal ENaC expression in the distal nephron and a very high capacity to reabsorb sodium against a steep gradient. Expect a long, salt-avid distal segment.
- Collecting duct: permanently water-impermeable, with no regulated aquaporin-2 trafficking, but with extensive sodium-reclaiming machinery. Urine would be copious and extremely dilute — close to pure water.
Moving it to a desert. It would die of hypernatremic dehydration, quickly. It has no medullary gradient, so even if it could produce ADH there would be nothing for the water to move into; the collecting duct is waterproof by construction; and its minimum obligatory urine volume is therefore enormous, since it must still excrete its daily solute load at an osmolality near or below plasma. Losing several litres a day of near-isosmotic or dilute urine while taking in nothing, it would lose extracellular volume and rise in plasma osmolality simultaneously. Circulating volume would fall, so cardiac output and blood pressure would fall, and — with its hypertrophied aldosterone system pointlessly retaining a mineral it has plenty of — it would arrive at circulatory collapse with a very high serum sodium.
The general point: the human kidney's design is not an optimum in the abstract. It is a compromise built for terrestrial life with intermittent, unreliable water — which is precisely why its most elaborate machinery, the countercurrent multiplier, exists to solve a problem that an aquatic animal does not have. Structure follows the environment as surely as it follows function.
Concept Map to Complete
Copy this onto blank paper and fill every bracket from memory before checking the chapter. Then, in a different colour, add what you missed.
GLOMERULAR FILTRATION RATE
│
┌───────────────────────────┼───────────────────────────┐
│ │ │
NFP = [ ___ ] − ( [ ___ ] + [ ___ ] ) Kf = [ ______ ] × [ ______ ]
= 55 − ( 15 + 30 ) = [ __ ] mm Hg
│
REGULATED BY THREE SYSTEMS
┌───────────────────────────┼───────────────────────────┐
[ AUTOREGULATION ] [ ______________ ] [ ______ ]
├─ [ ________ ] mechanism nerve type: __ renin →
│ (stretch → constrict) receptor: α1 → ___ [ ___ ] →
└─ [ ________ ] feedback receptor: β1 → ___ ACE →
sensor = [ ________ ] [ ___ ]
signal = [ ________ ] │
acts on = [ ________ ] arteriole 5 actions:
1 [ _________ ]
2 [ _________ ]
3 [ _________ ]
4 [ _________ ]
5 [ _________ ]
══════════════════════════════════════════════════════════════════
THE CARDIORENAL LOOP
↓ cardiac output → ↓ [ ___________ ] → [ ______ ] activated
→ Na+ and water [ ________ ] + [ ______________ ]
→ ↑ [ _______ ] and ↑ [ ________ ] → ↑ myocardial work
→ ↓ cardiac output [ this loop is ______ feedback ]
══════════════════════════════════════════════════════════════════
WHY CREATININE IS BLIND EARLY: P(cr) = production ÷ [ ____ ]
⇒ the relationship is a [ __________ ]
⇒ plus [ __________ ] reserve and compensatory [ ____________ ]
Lab / Self-Exploration
- Read your own urinalysis. If you have ever had one, find the report and interpret every line using the table in §26.8. Specific gravity tells you how concentrated the sample was; check whether it matches how much you had drunk that morning.
- Measure your own concentrating range over a day. Note the colour of your first urine of the morning and of a sample two hours after drinking half a litre of water. You are watching ADH switch on and off. (Colour is a crude proxy for osmolality; it is good enough to see the range.)
- Find your costovertebral angle. Place a hand flat over the angle between the twelfth rib and the vertebral column on each side and tap gently with the other fist. Nothing should hurt. This is the manoeuvre used to elicit the flank tenderness of pyelonephritis, and it works because the kidney lies directly deep to that point.
- Do the filtered-load arithmetic for yourself. Take your own most recent plasma glucose (or use 95 mg/dL), assume a GFR of 125 mL/min, and calculate your filtered glucose load in mg/min. Then calculate the plasma glucose at which you personally would begin to spill glucose in your urine, using a threshold load of 225 mg/min.
- Track a diuretic's timing. If you or a family member takes a loop diuretic, note the time of the dose and the times of urination for the following six hours. You will see the onset at 30–60 minutes, the peak at one to two hours, and the offset by six — and you will understand immediately why the dose is prescribed in the morning.
- Estimate your daily obligatory water loss. Assume a solute load of 700 mOsm/day and a maximum urine concentration of 1200 mOsm/kg. Calculate the minimum urine volume you must produce even if severely dehydrated. Then repeat with a maximum of 800 mOsm/kg, which is a reasonable figure for an 80-year-old, and compare.
Key Terms
acute kidney injury (AKI) · An abrupt fall in GFR, classified as prerenal (hypoperfusion), intrinsic (parenchymal damage), or postrenal (obstruction).
afferent arteriole · The vessel delivering blood to the glomerulus; its constriction lowers both renal blood flow and GFR.
albuminuria · Urinary loss of albumin, quantified as the albumin-to-creatinine ratio; a marker of glomerular barrier failure that rises years before creatinine does.
aldosterone · Adrenal steroid acting on collecting duct principal cells to increase ENaC-driven sodium reabsorption and potassium secretion; defends volume, not osmolality.
antidiuretic hormone (ADH, vasopressin) · Posterior pituitary hormone that inserts aquaporin-2 into the apical membrane of collecting duct principal cells, allowing water reabsorption; defends osmolality.
aquaporin-2 · The regulated water channel of the collecting duct; trafficked to the apical membrane by ADH within minutes.
Bowman's (glomerular) capsule · The cup-shaped blind end of the tubule surrounding the glomerulus; its visceral layer is formed by podocytes.
chronic kidney disease (CKD) · Kidney damage or reduced GFR persisting over three months, staged G1–G5 by GFR and A1–A3 by albuminuria.
clearance · The volume of plasma completely cleared of a substance per unit time; C = (U × V) ÷ P.
collecting duct · The final, hormonally regulated segment; site of action of aldosterone, ADH, and the natriuretic peptides.
countercurrent exchanger · The vasa recta, whose hairpin geometry and slow flow preserve the medullary gradient passively.
countercurrent multiplier · The loop of Henle, which multiplies a 200 mOsm single effect into a 900 mOsm axial gradient by counterflow.
creatinine · A muscle breakdown product freely filtered and slightly secreted; plasma concentration is inversely proportional to GFR, making it a late marker of kidney disease.
detrusor · The three-layered smooth muscle of the bladder wall; contracts under parasympathetic M3 stimulation during voiding.
efferent arteriole · The vessel draining the glomerulus; its constriction by angiotensin II lowers renal blood flow while raising GFR.
filtration fraction · GFR divided by renal plasma flow, normally about 20%; rises when the efferent arteriole constricts.
glomerular basement membrane · The middle filtration barrier; excludes proteins by size and, through heparan sulfate, by negative charge.
glomerular filtration rate (GFR) · The volume filtered by all glomeruli per minute; about 125 mL/min, or 180 L/day.
glomerulus · The high-pressure capillary tuft where filtration occurs.
juxtaglomerular complex · Macula densa, granular (renin-secreting) cells, and extraglomerular mesangial cells at the vascular pole; the site of tubuloglomerular feedback and renin release.
juxtamedullary nephron · The 15% of nephrons with long loops and vasa recta that build the medullary osmotic gradient.
loop of Henle · The hairpin segment whose water-permeable descending limb and salt-pumping, water-impermeable ascending limb constitute the countercurrent multiplier.
macula densa · Modified thick ascending limb cells that sense luminal NaCl and trigger tubuloglomerular feedback.
medullary osmotic gradient · The 300-to-1200 mOsm/kg ramp from corticomedullary junction to papilla, roughly half NaCl and half urea.
micturition reflex · The sacral reflex arc for voiding, gated by the pontine micturition centre under cortical control.
nephron · The functional unit of the kidney: renal corpuscle plus tubule. About one million per kidney, and never replaced after 36 weeks of gestation.
net filtration pressure (NFP) · Glomerular hydrostatic pressure minus the sum of capsular hydrostatic and blood colloid osmotic pressures; about 10 mm Hg.
Na⁺/K⁺ ATPase · The basolateral pump whose sodium gradient powers essentially every reabsorptive transporter in the nephron.
peritubular capillaries · The second capillary bed, at low hydrostatic and high oncotic pressure; the destination of reabsorbed fluid.
podocyte · The visceral epithelial cell of the glomerular capsule whose interdigitating foot processes form the filtration slits; terminally differentiated and not replaced.
proximal convoluted tubule (PCT) · The brush-bordered bulk absorber, reclaiming 65% of salt and water and 100% of glucose and amino acids, obligatorily and isosmotically.
renal autoregulation · Intrinsic maintenance of renal blood flow and GFR over a MAP of 80–180 mm Hg by the myogenic mechanism and tubuloglomerular feedback.
renal clearance ratio · A substance's clearance divided by inulin clearance; below 1 means net reabsorption, above 1 means net secretion.
renal corpuscle · Glomerulus plus glomerular capsule; the filtering apparatus.
renal threshold · The plasma concentration at which a substance first appears in urine; for glucose about 180 mg/dL, but determined by filtered load and therefore dependent on GFR.
renin–angiotensin–aldosterone system (RAAS) · The kidney-initiated cascade that raises blood pressure by vasoconstriction, efferent arteriolar constriction, proximal sodium reabsorption, aldosterone release, and ADH release with thirst.
retroperitoneal · Positioned behind the parietal peritoneum; describes the kidneys, ureters, and adrenal glands.
thick ascending limb · The water-impermeable, NKCC2-driven diluting segment; the active element of the countercurrent multiplier and the target of loop diuretics.
transport maximum (Tm) · The saturation rate of a carrier-mediated transporter; for glucose about 375 mg/min.
trigone · The smooth triangular region of the bladder floor bounded by the two ureteric orifices and the internal urethral orifice.
tubuloglomerular feedback · The macula densa's regulation of afferent arteriolar tone in response to luminal NaCl; the loop exploited by SGLT2 inhibitors.
urea recycling · ADH-dependent movement of urea from the inner medullary collecting duct into the interstitium and back into the loop, supplying about half the medullary gradient.
vasa recta · The long hairpin capillaries of juxtamedullary nephrons that preserve the medullary gradient by countercurrent exchange.
Next: Chapter 27 · The Reproductive System — where the gonads turn out to be endocrine organs whose products act on bone, blood vessels, and lipids, and where Amara's changing cardiovascular risk finally acquires a hormonal explanation.